Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029493	b-hhv6nh	— (—)	346	1022	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AD Calcineurin inhibitors

200

104.54

307.65

3.9

3.8

—

Transplanted organ and tissue status

199

208.99

307.65

4.1

1.0

—

ILD medications: immunosuppressive drugs

240

35.60

307.65

3.8

1.1

—

ILD medications

245

19.30

202.90

3.7

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

228

20.30

196.63

3.6

1.1

—

First line medication for Crohn's disease

234

17.14

185.56

3.8

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

221

106

13.61

181.79

3.6

1.4

—

ILD medications: azathioprine

65.54

176.59

4.6

1.0

—

L04AA Selective immunosuppressants

124

24.59

175.62

4.1

3.1

—

Fever of other and unknown origin

144

18.92

169.75

3.0

2.0

—

Dialysis, with operation codes

104

37.85

168.56

3.1

3.9

—

Nephropathy related operations

105

34.56

165.95

3.4

3.5

—

Azathioprine

29.78

146.69

4.6

3.2

—

Kidney transplant status

36.91

136.26

4.0

4.5

—

Dental caries

103

21.68

135.24

3.6

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

19.73

119.16

3.0

3.4

—

Molar incisor enamel hypoplasia, with caries

77.61

113.34

5.5

3.0

—

Second line medication for Crohn's disease

134

145

9.27

111.60

4.4

2.1

—

L04AX Other immunosuppressants

132

141

9.39

111.01

4.3

2.1

—

Hypoplasia of dental enamel

32.31

109.67

5.6

5.7

—

Explicit Sepsis

104

13.00

104.60

3.8

3.3

—

Other problems related to primary support group, including family circumstances

17.86

103.10

5.6

3.6

—

Chronic kidney disease

17.46

102.83

3.2

3.4

—

Renal failure

102

13.51

101.55

3.0

2.9

—

Liquid cancers, helper endpoint

13.99

99.61

2.9

3.5

—

Caries of dentine

20.37

99.29

2.9

1.1

—

Septicaemia

101

12.48

99.27

3.8

—

Other septicaemia

14.10

98.57

3.9

3.7

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

169

160

7.30

97.45

3.2

2.6

—

Implicit viral Sepsis

25.94

96.69

3.3

3.4

—

Viral Sepsis

25.94

96.69

3.3

3.4

—

Any gastric operation

117

21.77

94.65

3.5

1.4

—

GASTRO-related operations

117

21.77

94.65

3.5

1.4

—

Bacterial infection, other or unspecified

12.67

94.06

3.2

2.9

—

Molar incisor enamel hypoplasia

16.83

93.56

5.8

4.7

—

Diseases of liver

14.45

91.11

2.4

2.3

—

Inflammatory bowel disease treatment related agents

178

141

7.07

89.63

3.4

2.4

—

Other bacterial diseases

157

146

7.24

88.83

3.4

2.6

—

Hypoplasia of dental enamel , including avohilmo

16.47

88.35

5.6

5.4

—

Implicit viral Sepsis

16.29

86.39

3.1

3.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

10.37

86.17

5.3

2.5

—

Bacterial infection, other or unspecified

100

10.73

84.66

3.2

2.8

—

Other diseases of blood and blood-forming organs, wide

16.39

83.03

3.0

3.1

—

Other bacterial diseases

160

156

6.52

80.66

3.3

2.7

—

Anaemias

21.05

75.71

3.8

2.2

—

All chronic kidney diseases

109

110

8.13

74.54

3.0

—

Gingival hyperplasia

22.94

72.37

5.0

4.8

—

Agranulocytosis

24.24

67.39

3.5

3.6

—

Influenza and pneumonia

154

180

5.45

66.04

2.9

3.0

—

Implicit Sepsis

104

103

7.63

65.11

2.6

—

Implicit Sepsis

110

112

7.19

64.65

2.6

2.4

—

Care involving dialysis

23.31

63.56

4.0

3.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

113

115

6.95

63.45

2.5

—

Other viral diseases

135

6.98

61.76

4.5

3.3

—

All kidney diseases

142

182

5.34

61.69

3.1

2.8

—

Bacterial Sepsis

11.06

61.67

2.7

3.1

—

Implicit bacterial Sepsis

13.22

60.11

2.6

—

Other viral diseases

101

160

6.29

60.08

4.2

3.0

—

General symptoms and signs

119

7.65

59.72

2.2

1.9

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

106

7.65

59.30

2.5

2.0

—

106

7.65

59.30

2.5

2.0

—

Viral infections characterized by skin and mucous membrane lesions

139

6.71

59.05

3.6

3.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

113

179

5.70

58.72

3.6

2.5

—

Implicit bacterial Sepsis

12.48

58.25

2.6

2.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

114

125

6.30

58.19

2.6

—

Renal tubulo-interstitial diseases

124

171

5.41

56.64

3.0

2.6

—

Cardiovascular diseases (excluding rheumatic etc)

123

115

6.16

56.36

3.9

3.3

—

Certain infectious and parasitic diseases

106

8.18

55.63

3.2

1.7

—

Dialysis

21.03

54.11

4.5

4.7

—

Acute renal failure

17.99

53.31

2.6

2.3

—

Hypertensive diseases (excluding secondary)

8.13

50.28

3.7

2.8

—

Antihypertensive medication - note that there are other indications

115

100

6.11

50.17

4.5

2.8

—

Cardiovascular diseases

116

107

5.84

49.03

4.0

3.5

—

Pneumonias (Asthma/COPD co-morbidities)

133

196

4.56

48.49

2.9

3.0

—

Persons encountering health services for specific procedures and health care

142

191

4.46

48.20

3.0

2.9

—

Aplastic and other anaemias

7.84

48.18

3.0

2.9

—

Intestinal infectious diseases

123

201

4.65

48.08

3.4

2.3

—

Viral warts

16.14

46.93

4.2

3.8

—

Gastrointestinal diseases

12.82

46.26

3.8

1.3

—

All pneumoniae

134

206

4.35

46.19

2.8

3.0

—

Examination and observation for other reasons

9.79

45.61

2.5

1.2

—

All influenza

9.05

45.03

3.5

4.3

—

Any reimbursement code in KELA

11.94

44.80

3.7

1.0

—

Pneumonia, organism unspecified

114

171

4.68

43.58

2.8

3.1

—

Other viral diseases, not elsewhere classified

100

6.72

42.58

5.4

3.8

—

Coagulation defects, purpura and other haemorrhagic conditions

9.29

40.91

2.2

4.5

—

Other viral diseases, not elsewhere classified

131

5.72

40.64

4.9

3.4

—

Glomerular diseases

9.46

40.61

3.6

3.5

—

Medical observation and evaluation for suspected diseases and conditions

8.69

40.44

2.7

1.3

—

Nausea and vomiting

7.19

40.34

3.5

3.8

—

Acute upper respiratory infections of multiple and unspecified sites

130

5.19

39.92

3.5

2.1

—

Bronchitis

106

140

4.77

39.70

3.0

1.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

125

212

4.03

39.51

2.8

3.0

—

Purpura and other haemorrhagic conditions

11.89

38.52

2.0

5.0

—

Heart failure, not strict

118

5.13

37.18

2.6

2.5

—

Neoplasms

114

135

4.48

36.95

3.8

3.0

—

Viral and other specified intestinal infections

6.95

36.45

3.9

3.6

—

Glomerulonephritis

11.27

36.23

3.7

3.9

—

Other medical care

7.29

36.10

2.2

3.1

—

Infections, IBD-co-morbidities

12.55

35.27

2.5

4.3

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

13.98

34.77

3.0

2.0

—

Hypertensive diseases

100

124

4.56

34.02

3.4

2.3

—

Hypertension

100

124

4.56

34.01

3.4

2.3

—

Viral and other specified intestinal infections

5.98

33.76

3.8

3.2

—

Viral infections characterized by skin and mucous membrane lesions

104

231

3.85

33.55

3.2

2.8

—

Malignant neoplasm

132

4.44

33.40

3.2

2.8

—

Covid-19 confirmed case

6.56

33.07

2.6

3.0

—

Other congenital malformations of the digestive system

8.12

32.64

5.2

5.4

—

Other anaemias

6.74

32.03

3.1

2.7

—

Other heart diseases

5.43

31.78

3.1

3.8

—

Other and unspecified anaemias

6.82

31.75

3.1

2.7

—

Nephrotic syndrome

12.70

31.60

3.9

4.8

—

Failure and rejection of transplanted organs and tissues

64.48

31.51

3.8

7.2

—

COPD/asthma/ILD related infections

5.13

31.30

2.8

2.0

—

COPD/asthma related infections

5.13

31.30

2.8

2.0

—

Codes for special purposes

145

4.76

30.64

2.7

—

Provisional assignment of new diseases of uncertain etiology

145

4.76

30.64

2.7

—

Malignant neoplasm, wide definition for exclusion

136

4.19

30.47

3.2

2.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

104

183

3.75

29.71

3.2

2.4

—

Any event in cancer register

143

4.04

29.54

2.9

2.8

—

Other special examinations and investigations of persons without complaint or reported diagnosis

7.07

28.82

3.2

1.3

—

Oral corticosteroids

121

4.27

28.14

1.6

1.8

—

Any death

5.52

27.69

1.9

2.1

—

Complications of medical and surgical care

150

4.36

27.61

3.2

2.2

—

General examination and investigation of persons without complaint and reported diagnosis

6.92

27.44

3.6

1.3

—

Non-Hodgkin lymphoma, all, including Hilmo

30.18

27.17

1.9

2.7

—

115

4.14

27.05

2.8

1.9

—

Secondary hypertension

26.34

26.87

3.7

3.6

—

Other congenital malformations of the digestive system

6.58

26.59

5.3

—

Bacterial pneumoniae

6.51

26.57

2.4

3.2

—

Complications of surgical and medical care, not elsewhere classified

166

3.76

26.48

3.1

2.2

—

All influenza (not pneumonia)

9.18

26.47

3.2

3.9

—

Anomalies of dental arch relationship, including avohilmo

5.56

26.00

4.4

3.5

—

Bacterial pneumonia, not elsewhere classified

6.61

25.14

2.3

3.4

—

Certain disorders involving the immune mechanism

6.94

24.98

6.4

3.2

—

Cholangitis (primary sclerosing, PSC)

26.47

24.86

4.5

3.2

—

Other reaction to severe stress, and adjustment disorders

100

5.11

24.66

4.5

2.3

—

Disorders of tooth development and eruption

10.07

24.61

4.1

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

122

4.62

24.39

3.5

2.1

—

Metabolic disorders

168

3.49

24.24

2.6

—

Viral warts

6.14

24.04

4.1

3.1

—

Intestinal infectious diseases

105

182

3.30

23.86

2.9

2.4

—

Mycoses

7.16

23.70

2.3

3.0

—

Other acute lower respiratory infections

181

3.80

23.62

3.2

3.4

—

Acute upper respiratory infections

141

3.72

23.51

3.3

2.1

—

Bacterial pneumonia (organism specified)

5.03

23.48

2.4

3.0

—

Acute tubulo-interstitial nephritis

126

4.25

22.97

3.6

2.9

—

Extracorporeal dialysis

20.90

22.56

3.9

3.6

—

Enlarged lymph nodes

20.70

22.51

2.7

3.2

—

Symptoms and signs involving the digestive system and abdomen

102

154

3.32

22.33

3.2

2.8

—

Other disorders of fluid, electrolyte and acid-base balance

6.90

21.85

2.9

2.7

—

Acute suppurative otitis media

106

4.59

21.72

3.7

3.3

—

Oxycodone

6.32

21.51

1.5

1.4

—

Crossbite

5.19

21.44

4.8

5.0

—

Reimbursement for rheumatic diseases

142

4.07

21.26

3.7

2.5

—

Pulmonary heart disease, diseases of pulmonary circulation

7.51

21.18

1.5

2.0

—

Congenital malformation of biliary tract

33.34

20.95

6.1

3.8

—

Certain infectious and parasitic diseases

5.41

20.80

3.9

1.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5.92

20.58

2.7

2.6

—

Fibrosis and cirrhosis of liver

32.76

20.17

3.2

3.0

—

Thrombocytopenia, unspecified

20.91

19.92

2.3

5.3

—

Cytomegaloviral disease

36.70

19.92

2.7

5.7

—

Congenital malformations of gallbladder, bile ducts and liver

23.29

19.83

6.1

3.8

—

Unspecified jaundice

40.47

19.51

3.7

3.8

—

Care involving use of rehabilitation procedures

163

3.61

19.46

3.3

3.0

—

Otitis media, unspecified

5.39

19.42

4.5

4.2

—

Disorders of gallbladder, biliary tract and pancreas

141

3.45

19.42

4.0

1.7

—

Other/unspecified cytomegaloviral diseases

32.33

19.37

2.7

6.1

—

Convulsions, not elsewhere classified

7.00

19.15

4.4

2.7

—

Headache

4.86

19.09

3.4

1.9

—

Pain, not elsewhere classified

8.08

18.74

2.1

2.4

—

Infections of the skin and subcutaneous tissue

217

3.24

18.66

4.1

2.7

—

Cytomegalovirus infection, IBD co-morbidity

25.71

18.30

2.7

5.2

—

Erosion of teeth , including avohilmo

4.83

18.20

5.0

2.9

—

Speech and linguistic disorders, excluding more controls

5.41

18.14

4.7

4.4

—

Other diseases of the digestive system

5.39

18.02

4.2

3.4

—

Crowding of teeth, including avohilmo

4.86

17.96

4.4

4.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

121

4.03

17.92

4.1

4.5

—

Non-follicular lymphoma

22.87

17.72

1.7

2.7

—

Other pulmonary diagnosis

4.66

17.69

3.2

2.0

—

Excluding asthma or asthma-COPD overlap

4.66

17.69

3.2

2.0

—

COPD differential diagnosis

4.66

17.69

3.2

2.0

—

ILD differential diagnosis

4.66

17.69

3.2

2.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

118

4.04

17.64

4.2

4.6

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

130

3.78

17.64

3.9

4.2

—

Disorders of psychological development

108

4.15

17.62

4.5

—

Endocrine, nutritional and metabolic diseases

144

3.10

17.53

3.4

3.1

—

Other dialysis

21.27

17.34

4.6

3.9

—

Nonsuppurative otitis media

4.34

17.18

4.0

3.5

—

Other diseases of biliary tract

19.35

16.85

4.2

2.5

—

Suppurative and unspecified otitis media

122

3.78

16.74

3.8

3.0

—

Acute pharyngitis

6.01

16.63

3.3

3.6

—

Acute bronchitis

125

3.85

16.63

2.8

3.9

—

Genitourinary diseases

121

3.24

16.57

4.3

3.3

—

Disorders resulting from impaired renal tubular function

27.92

16.52

4.1

3.1

—

Persons with potential health hazards related to communicable diseases

179

3.33

16.47

4.4

3.5

—

Hypoplasia of dental enamel, prenatal

28.76

16.45

6.3

3.6

—

Other disorders of kidney and ureter

13.40

16.43

3.4

2.3

—

Nutritional anaemias

112

3.96

16.19

2.8

3.0

—

Drug-induced neutropenia

30.21

16.10

2.2

1.7

—

Lymphoid leukaemia

13.65

15.98

4.9

4.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

11.41

15.94

3.6

2.0

—

Solid cancers, helper endpoint

116

3.36

15.78

2.1

2.4

—

GI-bleeding

5.01

15.68

4.2

3.4

—

Heart failure and antihypertensive medication

6.55

15.62

2.5

2.0

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

22.66

15.62

4.6

3.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

19.54

15.59

8.7

5.3

—

Other disorders involving the immune mechanism, not elsewhere classified

19.51

15.58

8.7

5.3

—

Iron deficiency anaemia

102

4.06

15.39

2.8

3.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

189

2.70

15.35

2.7

2.8

—

Caries of enamel

198

2.84

15.19

4.3

1.7

—

Disorders of other endocrine glands

178

3.21

15.03

4.1

3.5

—

Other metabolic disorders

10.81

14.94

1.7

3.1

—

Abnormal findings on examination of blood, without diagnosis

100

3.95

14.89

3.2

2.7

—

Persons encountering health services in other circumstances, wide

189

2.62

14.51

2.9

2.8

—

Pulmonary embolism

6.58

14.44

1.3

1.4

—

Pulmonary heart disease

6.58

14.44

1.3

1.4

—

Other heart diseases, wide

214

2.60

14.37

2.7

3.0

—

Symptoms and signs concerning food and fluid intake

16.97

14.26

4.5

4.1

—

Symptoms and signs involving the skin and subcutaneous tissue

199

3.00

14.15

2.7

2.5

—

Diseases of the digestive system

134

3.49

13.99

3.6

3.1

—

Cutaneous abscess, furuncle and carbuncle

4.78

13.98

3.4

2.8

—

Cirrhosis of liver, NAS

30.25

13.88

2.7

3.2

—

Hernia of abdominal wall, postoperative

30.05

13.86

1.6

1.8

—

Secondary and unspecified malignant neoplasm of lymph nodes

23.86

13.77

1.2

4.9

—

Other and unspecified tonsillitis

3.92

13.71

3.6

2.5

—

Congenital malformations of the urinary system

5.73

13.67

3.4

5.8

—

Speech and linguistic disorders

104

3.81

13.63

4.7

4.6

—

Implicit fungal Sepsis

34.19

13.50

3.4

2.6

—

Abdominal and pelvic pain

154

2.71

13.31

3.4

2.8

—

Hard cardiovascular diseases

165

2.75

13.23

2.3

3.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

16.74

12.96

2.9

2.7

—

Unspecified kidney failure

28.43

12.94

2.4

3.7

—

Other and unspecified dermatitis

137

3.36

12.94

2.7

—

Need for other prophylactic measures

13.05

12.91

5.5

5.3

—

Ischemic heart diseases

162

2.75

12.89

2.4

3.1

—

Congenital malformations of the urinary system

5.63

12.89

3.5

5.9

—

Zoster [herpes zoster]

4.06

12.84

2.7

1.7

—

Syncope and collapse

6.16

12.80

2.7

2.2

—

Heart failure,strict

4.41

12.79

2.3

2.2

—

Osteopathies and chondropathies

142

3.22

12.65

3.3

2.8

—

Other diseases of liver

10.98

12.49

2.4

2.1

—

Malaise and fatigue

4.74

12.48

2.7

2.4

—

Viral pneumonia

9.29

12.44

2.4

3.9

—

Percutaneous Coronary Intervention

159

2.74

12.42

2.2

3.1

—

Coronary revascularization (ANGIO or CABG)

159

2.74

12.39

2.2

3.1

—

Diseases of the skin and subcutaneous tissue

149

2.66

12.29

2.9

2.5

—

Major coronary heart disease event

164

2.69

12.28

2.2

3.1

—

Secondary uncertain malignant neoplasm

14.33

12.25

1.2

3.6

—

Lack of expected normal physiological development

10.21

12.19

4.7

4.1

—

Rare circulating lymphoid malignancy, including Hilmo

12.56

12.14

6.0

5.4

—

Excessive attrition of teeth

190

2.90

12.11

4.1

2.2

—

Other bacterial intestinal infections

6.01

12.11

1.8

2.5

—

Asthma (only as main-diagnosis), excluding more controls

4.18

12.02

2.4

2.0

—

Oesophageal varices

21.46

12.01

4.3

4.1

—

DVT of lower extremities and pulmonary embolism

4.57

12.01

1.3

—

Emergency coronary revascularization (for ACS)

165

2.65

11.88

2.2

3.1

—

Other and unspecified iron deficiency

3.98

11.87

2.7

3.2

—

Dentofacial anomalies [including malocclusion]

173

2.79

11.70

3.2

2.0

—

Specific development disorders of scholastic skills

4.80

11.67

6.5

4.6

—

Hypoplasia of dental enamel, prenatal , including avohilmo

10.83

11.67

6.3

4.0

—

Myeloid leukaemia

30.41

11.66

1.7

6.4

—

Glomerular disorders in diseases classified elsewhere

12.55

11.61

3.3

2.9

—

Other disorders starting during childhood or adolecense, excluding more controls

4.51

11.58

5.6

4.3

—

Congenital malformations, deformations and chromosomal abnormalities

214

2.67

11.54

3.9

2.4

—

Recurrent aphthous stomatitis , including avohilmo

5.24

11.52

7.7

4.3

—

Zoster [herpes zoster]

9.22

11.46

3.4

1.8

—

Personal history of other diseases and conditions

9.99

11.43

3.7

1.3

—

Polyneuropathies and other disorders of the peripheral nervous system

5.38

11.33

3.6

2.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

11.80

11.30

1.3

3.2

—

Venous thromboembolism

3.84

11.23

1.5

—

Other diseases of hard tissues of teeth

3.91

11.22

4.8

1.1

—

Acute sinusitis

110

3.37

11.12

2.8

1.7

—

Other postsurgical states

20.10

11.12

3.6

1.0

—

Anxiety disorders, excluding more controls

151

2.72

11.09

4.1

2.0

—

Dermatitis

172

2.90

11.04

2.9

2.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

11.15

11.02

1.6

3.2

—

Asthma, excluding more controls

3.91

11.00

2.4

2.0

—

8.54

11.00

2.4

3.1

—

Asthma (only as main-diagnosis)

3.86

10.99

2.4

2.0

—

Haemorrhage from respiratory passages

4.10

10.92

3.7

2.5

—

Congenital malformations, deformations and chromosomal abnormalities

207

2.67

10.89

4.0

2.5

—

Heart failure, strict

3.86

10.88

2.3

2.1

—

Bleeding

186

2.56

10.84

3.6

2.6

—

Abnormal findings on diagnostic imaging of lung

4.09

10.72

1.4

1.8

—

Stomatitis and related lesions

4.42

10.70

7.1

3.6

—

Diseases of middle ear and mastoid

158

2.80

10.69

3.7

2.6

—

Budesonide

12.89

10.63

1.8

1.7

—

Opioids

116

2.78

10.60

2.2

1.6

—

All-cause Heart Failure

3.95

10.58

2.4

2.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

6.30

10.38

3.4

2.0

—

Abnormalities of breathing

183

2.41

10.32

2.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

209

2.28

10.28

2.3

3.2

—

Cystic kidney disease

18.96

10.27

3.1

5.3

—

Autoimmune diseases excluding thyroid diseases

212

2.27

10.24

2.3

3.2

—

Ascites

23.43

10.23

3.0

1.0

—

Oedema, not elsewhere classified

8.05

10.18

1.8

1.9

—

Certain conditions originating in the perinatal period

3.42

10.10

4.7

4.5

—

Neurotic, stress-related and somatoform disorders

198

2.44

10.08

4.1

2.2

—

Intestinal stricture

4.45

9.99

2.5

2.7

—

Asthma

3.59

9.90

2.4

2.0

—

Anxiety disorders

199

2.42

9.89

4.1

2.2

—

Cystic kidney disease

16.84

9.88

3.1

4.8

—

Localized swelling, mass and lump of skin and subcutaneous tissue

3.71

9.84

2.5

2.9

—

Herpesviral [herpes simplex] infections

12.18

9.83

2.9

2.5

—

Enterocolitis due to Clostridium difficile

13.37

9.65

1.4

3.6

—

Other bacterial intestinal infections

8.35

9.53

1.8

3.0

—

Leukaemia of unspecified cell type

+∞

9.41

4.4

0.0

—

Acute bronchiolitis

3.31

9.39

4.3

5.0

—

Presence of cardiac and vascular implants and grafts

4.96

9.38

1.5

1.2

—

Non-ischemic cardiomyopathy

4.63

9.37

2.7

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.18

9.30

6.2

4.1

—

Other diseases of the respiratory system

4.89

9.29

2.5

4.1

—

Other respiratory disorders and diseases

4.89

9.29

2.5

4.1

—

Malignant neoplasm of digestive organs

5.27

9.28

3.9

1.7

—

Depression medications

6.22

9.22

2.8

1.6

—

Other endocrine disorders

3.58

9.19

5.1

5.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

126

3.01

9.05

3.9

2.0

—

Astigmatism

4.59

9.04

4.7

5.3

—

Persons encountering health services for examination and investigation

3.85

9.03

3.4

1.3

—

Osteoporosis

5.08

9.02

4.3

3.0

—

Disorders of refraction and accommodation

148

2.83

8.95

4.7

3.8

—

Other and unspecified drugs and medicaments

12.55

8.85

2.9

3.8

—

Diseases of the eye and adnexa

170

2.27

8.83

3.5

2.9

—

Tramadol

2.94

8.83

1.7

1.3

—

Cardiomyopathy

6.79

8.81

3.2

3.6

—

Asthma-related pneumonia

118

3.05

8.75

2.9

3.7

—

Heart failure and coronary heart disease

4.22

8.75

2.3

2.4

—

Cerebrovascular diseases (FINNGEN)

4.72

8.74

2.8

2.2

—

Open bite

4.26

8.66

3.7

5.3

—

Asthma, hospital admissions 3, pneumonia

119

3.02

8.63

2.9

3.8

—

Asthma-related pneumonia or sepsis

119

3.02

8.63

2.9

3.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

150

2.48

8.61

2.7

1.9

—

Paralytic ileus and intestinal obstruction

4.55

8.56

2.6

2.5

—

Other complications of surgical and medical care, not elsewhere classified

10.03

8.51

2.6

3.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

135

2.78

8.51

1.6

2.5

—

Autoimmune diseases related-to ILD

219

2.34

8.50

2.5

2.6

—

Dermatitis and eczema

236

2.13

8.49

2.6

2.9

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

210

2.46

8.41

4.4

3.2

—

Acute peritonitis

12.79

8.36

3.2

4.3

—

5-aminosalicylic acid

4.87

8.35

1.7

2.6

—

Diseases of the respiratory system

3.44

8.30

3.7

2.1

—

Candidiasis

8.52

8.29

2.9

2.0

—

Gout

4.78

8.28

1.4

1.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

9.45

8.26

2.8

3.9

—

Explicit bacterial Sepsis

9.44

8.26

4.1

—

Disorders of lens

2.83

8.14

2.2

1.9

—

Other diseases of intestines

242

2.05

8.09

2.8

3.1

—

Congenital malformations of the circulatory system

120

2.92

8.07

5.1

4.5

—

Cellulitis

3.76

8.05

3.6

3.2

—

Procreative management

153

2.56

8.02

3.2

3.9

—

Bacterial intestinal infections, IBD co-morbidities

6.26

7.99

1.8

3.3

—

Childhood asthma (age<16), excluding more controls

9.71

7.98

3.4

4.5

—

Cardiomyopathy (excluding other)

8.44

7.80

3.3

—

Streptococcal septicaemia

9.41

7.77

4.0

4.7

—

Other cataract

3.65

7.74

3.0

2.1

—

Urticaria and erythema

144

2.71

7.73

4.3

3.3

—

Melanocytic naevi

3.64

7.71

4.3

2.2

—

Asthma, unspecified (mode), excluding more controls

3.74

7.68

1.9

—

Gout, FINNGEN

6.32

7.67

1.4

1.1

—

Hyperkinetic disorders, excluding more controls

3.66

7.66

3.6

3.3

—

Other noninfective gastroenteritis and colitis

117

2.91

7.66

2.3

4.1

—

Hypo-osmolality and hyponatraemia

7.36

7.62

3.6

2.3

—

Non-invasive ventilation

3.93

7.62

4.6

2.4

—

Other and unspecified disorders of white blood cells

18.45

7.60

2.5

3.0

—

Cardiomyopathies, Primary/intrinsic

8.02

7.58

3.3

3.2

—

Acute generalized exanthematous pustulosis

11.90

7.58

2.1

4.6

—

Congenital malformations of heart and great arteries

114

2.90

7.56

4.4

4.9

—

Herpesviral [herpes simplex] infections

4.09

7.52

2.7

2.0

—

Asthma (mode)

3.19

7.47

2.5

2.0

—

Tooth eruption problems

100

3.03

7.45

5.2

4.5

—

Childhood asthma (age<16)

8.42

7.43

3.4

4.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.15

7.42

5.4

4.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

6.44

7.39

2.9

2.7

—

Other disorders of white blood cells

13.40

7.38

2.9

3.3

—

Gingivitis and periodontal diseases

150

2.24

7.35

4.3

2.4

—

Hepatomegaly and splenomegaly, not elsewhere classified

+∞

7.31

3.7

0.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

+∞

7.30

1.9

0.0

—

Multiple myeloma

+∞

7.30

1.9

0.0

—

Drug-induced polyneuropathy

16.21

7.28

5.3

4.9

—

Other necrotizing vasculopathies

15.77

7.22

4.5

4.9

—

Noninfective enteritis and colitis

203

2.36

7.21

2.0

3.5

—

Pacemaker

4.32

7.17

2.8

2.7

—

Melanocytic naevi of trunk

7.91

7.09

4.3

2.3

—

Diseases of peritoneum

8.77

7.04

3.2

3.4

—

Asthma, unspecified (mode)

3.49

7.01

1.9

—

Systemic connective tissue disorders

3.61

7.01

3.4

2.3

—

Other congenital malformations of urinary system

14.46

6.98

4.6

7.9

—

Complications of procedures, not elsewhere classified

148

2.46

6.95

2.8

2.2

—

Acute laryngitis and tracheitis

5.51

6.94

4.7

4.5

—

Varicella [chickenpox]

8.29

6.82

3.4

4.3

—

Atrial fibrillation and flutter

4.40

6.79

1.9

1.4

—

Other infectious diseases

10.94

6.79

2.0

2.9

—

Preparatory care for dialysis

16.76

6.74

3.1

3.0

—

Non-allergic asthma (mode), excluding more controls

7.08

6.64

3.7

3.1

—

Other disorders of skin and subcutaneous tissue

153

2.44

6.63

2.6

2.3

—

Phobic anxiety disorders

4.00

6.60

3.5

3.3

—

Other infectious diseases

12.26

6.57

1.9

3.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

5.72

6.45

4.8

4.7

—

Non-allergic asthma (mode)

6.76

6.45

3.7

3.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

3.40

6.37

6.0

5.0

—

Statin medication

114

2.37

6.37

3.3

1.7

—

Elevated blood glucose level

8.15

6.32

4.6

5.4

—

Dermatitis due to substances taken internally

9.27

6.28

2.2

7.2

—

Aspergillosis

+∞

6.27

1.0

0.0

—

Protozoal diseases

18.13

6.27

3.4

3.0

—

Primary biliary cholangitis (PBC)

+∞

6.26

1.2

0.0

—

IgA nephropathy (IgA glomerulonephritis)

+∞

6.25

3.3

0.0

—

Benign neoplasms

181

2.04

6.25

2.7

2.6

—

Malnutrition

7.11

6.24

4.5

5.3

—

203

2.25

6.21

2.8

3.6

—

Symptoms and signs involving the circulatory and respiratory systems

184

1.99

6.20

3.5

2.7

—

Autoimmune diseases

216

1.91

6.16

2.5

3.1

—

Other diseases of pleura

2.96

6.14

2.6

—

Candidiasis

3.39

6.12

2.8

2.0

—

6-mercaptopurine

12.57

6.08

5.1

3.1

—

Other necrotizing vasculopathies (FG)

12.54

6.08

4.7

4.4

—

Generalized skin eruption due to drugs and medicaments

10.06

6.03

2.3

4.6

—

Varicella [chickenpox]

5.18

6.00

3.1

4.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

15.26

5.92

5.6

4.5

—

Used for control exclusion in common control thyroid runs

211

1.89

5.88

2.7

3.1

—

Asthma, hospital admission 2, infections

231

2.12

5.86

2.7

3.3

—

Asthma-related infections

231

2.12

5.86

2.7

3.3

—

Diseases of oral cavity, salivary glands and jaws

2.90

5.84

3.7

1.1

—

Cardiac arrhythmias

124

2.31

5.77

2.3

3.0

—

Erysipelas

2.77

5.69

1.4

1.8

—

Neurological diseases, wide definition

2.71

5.68

4.9

4.1

—

Other or unspecified ileus, impaction or obstruction

6.09

5.68

2.8

2.2

—

Left ventricular outflow tract obstruction, narrow definition

3.72

5.64

4.7

5.3

—

Hypokalaemia

7.51

5.62

2.7

3.4

—

Osteonecrosis

12.90

5.58

3.2

1.3

—

Deep bite

100

2.64

5.56

4.7

4.5

—

Hernia

193

2.01

5.54

2.9

2.3

—

Other skin changes

5.84

5.52

1.8

2.8

—

Short stature, not elsewhere classified

2.98

5.51

5.7

5.4

—

Exclusions for E4_PCOS_BROAD

105

2.67

5.47

3.3

4.6

—

Nonischemic cardiomyopathy

7.07

5.43

2.7

3.4

—

Multiple myeloma and malignant plasma cell neoplasms

16.07

5.41

1.8

3.6

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

16.05

5.41

5.3

3.6

—

Acute lymphocytic leukaemia, helper endpoint

8.15

5.40

8.0

5.3

—

Acute lymphocytic leukaemia

8.15

5.40

8.0

5.3

—

Acute lymphocytic leukaemia, including Hilmo

8.15

5.40

8.0

5.3

—

Other disorders starting during childhood or adolescence

105

2.66

5.39

5.6

5.0

—

Inflammatory bowel disease

106

2.64

5.38

1.7

3.5

—

Alcoholic liver disease

11.27

5.29

1.0

—

Cardiomyopathy, other and unspecified

9.11

5.28

2.4

3.9

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

+∞

5.22

2.2

0.0

—

Disorders of brain, other and unspecified

+∞

5.22

3.8

0.0

—

Myelodysplastic syndrome

+∞

5.22

1.4

0.0

—

Chronic hepatitis NAS

+∞

5.22

1.2

0.0

—

Osteonecrosis due to drugs

+∞

5.21

4.6

0.0

—

Abnormal serum enzyme levels

3.38

5.21

3.0

2.7

—

Special screening examination for infectious and parasitic diseases

4.09

5.19

2.3

1.2

—

Hypothyroidism and >3 levothyroxin purchases

4.47

5.18

2.7

2.5

—

Hypothyroidism, levothyroxine purchases

4.47

5.18

2.7

2.5

—

Hypothyroidism (congenital or acquired)

4.46

5.17

2.7

2.5

—

Paroxysmal tachycardia

3.93

5.13

3.1

4.4

—

Any mental disorder

180

1.89

5.10

3.4

2.3

—

Disorders in reading

6.41

5.10

8.5

6.4

—

Factors influencing health status and contact with health services

6.39

5.07

2.7

1.2

—

Immunodeficiency with predominantly antibody defects

8.40

5.06

5.8

5.5

—

Cholecystitis

8.34

5.05

2.0

1.9

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

3.56

5.04

3.4

4.9

—

Malignant neoplasm of eye, brain and central nervous system

10.04

5.02

1.4

4.9

—

Dyspnoea

203

1.97

4.97

2.2

2.4

—

Volume depletion

6.89

4.94

4.6

4.0

—

Diseases of oesophagus, stomach and duodenum

208

1.87

4.94

1.9

2.6

—

Immunodeficiencies

6.03

4.91

5.0

4.6

—

Pain (limb, back, neck, head abdominally)

141

1.99

4.86

4.2

2.8

—

Disorders of mineral metabolism

7.71

4.84

3.9

3.5

—

Type of accident

2.70

4.83

3.9

2.8

—

Covid-19 suspected case

2.99

4.81

3.1

3.3

—

Cough

141

2.28

4.79

4.0

3.1

—

Polycystic kidney disease

11.51

4.79

3.3

4.6

—

Other encephalitis

11.50

4.79

1.4

6.7

—

Viral pneumonia (unknown virus, not influenza)

6.49

4.77

2.4

2.8

—

Invasive ventilation

5.73

4.75

3.1

3.8

—

Disturbance of activity and attention

2.68

4.73

3.6

4.4

—

Codeine

108

2.16

4.72

1.8

1.4

—

Viral pneumonia (known virus, not influenza)

7.20

4.66

3.5

5.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.58

4.62

3.8

3.0

—

Other symptoms and signs involving the digestive system and abdomen

5.01

4.62

3.3

2.9

—

Disorders of skin appendages

165

2.18

4.61

2.6

2.9

—

Inflammatory diseases of the central nervous system

6.13

4.60

1.7

3.8

—

Sequelae of external causes of morbidity and mortality

3.34

4.59

2.9

2.5

—

Anaemia in chronic diseases classified elsewhere

14.09

4.58

4.4

4.8

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

14.04

4.57

5.9

3.6

—

Sequelae of other external causes

14.04

4.57

3.3

2.8

—

Specific development disorders of speech and language

2.68

4.53

4.3

5.0

—

Encephalitis

10.06

4.52

1.4

6.1

—

Other pulmonary heart/vessel disease

10.04

4.52

2.0

5.0

—

Valvular heart disease excluding rheumatic fever

2.33

4.50

3.8

3.2

—

Diseases of the ear and mastoid process

189

1.81

4.49

2.8

2.2

—

Acute pancreatitis

4.82

4.49

4.4

1.9

—

Pruritus

6.68

4.46

4.1

2.7

—

Polyarthropathies

149

2.02

4.46

1.7

2.8

—

Finngen Rheumatological endpoints

180

1.86

4.44

2.2

2.7

—

Diseases of salivary glands

2.93

4.43

1.7

2.5

—

IBD patients in KELA-register

2.82

4.38

1.5

3.9

—

Undetermined asthma, excluding more controls

7.50

4.35

3.0

3.4

—

Undetermined asthma

7.50

4.35

3.0

3.4

—

Other diseases of anus and rectum

3.09

4.33

2.5

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

3.20

4.33

1.3

3.3

—

Continuous positive airway pressure

2.77

4.28

3.6

3.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

11.69

4.27

2.1

4.3

—

ILD, hospital admissions 3, with pneumonia sepsis

11.69

4.27

1.3

2.7

—

Inflammatory bowel disease, strict (require KELA)

2.78

4.27

1.5

3.9

—

Presence of other devices

6.23

4.27

3.5

1.1

—

Pain in throat and chest

151

1.95

4.26

2.7

2.2

—

Urticaria

126

2.30

4.25

4.8

3.5

—

Diverticular disease of intestine

2.40

4.23

1.4

1.3

—

2.49

4.22

4.1

5.2

—

Hypertension, essential

100

2.15

4.20

1.6

1.7

—

Tooth agenesis EXCLUDE clefts and syndromes

3.87

4.19

3.9

5.9

—

Ulcerative colitis, NAS

3.42

4.18

1.9

4.5

—

Other and unspecified polyneuropathies, also in other diseases

4.81

4.18

2.3

1.2

—

Haemolytic anaemias

6.96

4.16

7.3

3.9

—

Congenital vesicoureteral reflux

8.22

4.09

3.9

7.6

—

Fitting and adjustment of other devices

3.42

4.07

2.4

2.5

—

Diaphragmatic hernia

3.08

4.07

2.4

1.4

—

Other diseases of arteries and capillaries

8.01

4.06

1.1

3.3

—

Leisure time condition

3.20

4.05

4.6

3.2

—

Haemorrhagic and haematological disorders of fetus and newborn

2.49

4.01

6.3

5.2

—

Emotional disorders starting during childhood or adolescence

2.69

4.01

6.1

4.9

—

Adrenocortical insufficiency

10.04

4.01

3.6

4.3

—

Acute pancreatitis (for exclusion)

4.20

4.00

4.4

2.2

—

Adjustment and management of implanted device

5.01

4.00

2.4

3.9

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.13

3.98

2.2

1.2

—

Ulcerative colitis

2.67

3.98

2.0

3.6

—

Excessive, frequent and irregular menstruation

2.68

3.96

2.8

2.0

—

Persons encountering health services in circumstances related to reproduction

210

1.80

3.94

3.1

3.3

—

Mood disorders, excluding more controls

142

1.93

3.93

1.8

1.6

—

Crohn disease

3.26

3.90

1.5

4.4

—

Other disorders of bone

3.26

3.90

4.2

2.8

—

Unspecified acute lower respiratory infection

3.79

3.88

2.4

3.4

—

Psychiatric diseases

172

1.78

3.87

3.6

2.4

—

Other respiratory diseases principally affecting the interstitium

4.79

3.86

1.3

1.6

—

Cerebral cysts

7.29

3.86

3.4

4.5

—

Delayed milestone in childhood

2.45

3.84

5.1

5.5

—

Other viral hepatitis

6.02

3.81

4.8

2.1

—

Viral hepatitis

6.01

3.81

4.8

2.1

—

Dermatophytosis

6.01

3.81

2.4

2.7

—

Erysipelas

2.79

3.80

1.6

1.8

—

Congenital malformations of aortic and mitral valves

3.96

3.79

5.0

5.7

—

Other diseases of pericardium

8.78

3.77

1.1

4.5

—

Granulomatous disorders of skin and subcutaneous tissue

12.06

3.76

1.7

6.4

—

Other specified disorders of kidney and ureter

12.05

3.76

2.0

3.2

—

Other aneurysm

12.03

3.76

5.8

1.4

—

Retinal vascular occlusion

12.01

3.76

1.5

1.2

—

Retinal vascular disorders

12.01

3.76

1.5

1.2

—

Diseases of arteries, arterioles and capillaries

2.23

3.75

2.7

1.6

—

Senile cataract

2.38

3.69

1.2

1.1

—

Missing teeth due to accident, extraction or parodontitis

108

2.27

3.68

1.2

1.8

—

Malignant neoplasm of brain, including Hilmo

6.69

3.67

1.8

5.1

—

AV-block

4.59

3.67

2.8

4.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.61

3.61

4.6

5.2

—

Nail disorders

4.77

3.55

2.5

4.0

—

Other diseases of intestine

4.77

3.55

4.1

2.4

—

Irregular menses

2.26

3.52

2.2

2.0

—

Embedded and impacted teeth

101

2.21

3.51

3.4

3.7

—

Hydronephrosis

5.30

3.50

3.0

4.0

—

Other and unspecified erythematous conditions

10.04

3.50

3.7

5.5

—

Other erythematous conditions

10.04

3.50

3.7

5.5

—

Benign neoplasm: Skin of trunk

10.03

3.50

2.8

3.7

—

Vitamin deficiency, wide

10.03

3.50

5.3

2.8

—

Vitamin deficiency

10.03

3.50

5.3

2.8

—

Emphysema

10.02

3.49

1.7

—

Motor disorders, excluding more controls

3.05

3.44

5.0

4.8

—

Anti-inflammatory and antirheumatic products, non-steroids

108

0.28

3.43

5.3

4.3

—

Propionic acid derivatives

108

0.28

3.43

5.3

4.3

—

Noninfectious colitis NAS

2.98

3.40

2.4

4.2

—

Rash and other nonspecific skin eruption

4.08

3.39

4.8

4.3

—

Other disorders of adrenal gland

5.02

3.37

3.2

4.9

—

Other embolism and thrombosis

5.01

3.36

1.7

2.3

—

Non-rheumatic valve diseases

2.19

3.36

3.4

2.8

—

Speech therapy

2.83

3.35

2.5

2.4

—

Hypermetropia

2.84

3.35

5.0

5.1

—

Seborrhoeic dermatitis

5.72

3.34

2.8

5.0

—

Diseases of pulp and periapical tissues and dental caries

2.01

3.32

3.3

2.2

—

Bacterial, viral and other infectious agents

3.94

3.28

4.9

3.5

—

2.33

3.27

4.2

5.3

—

Other congenital malformations of heart

4.86

3.26

3.7

5.6

—

Malignant neoplasm of brain

8.60

3.26

1.7

5.0

—

Other diseases of blood and blood-forming organs

8.59

3.26

1.3

2.0

—

Chronic periodontitis, including avohilmo

148

1.86

3.26

1.9

1.5

—

Periodontitis

149

1.84

3.18

1.9

1.5

—

Valvular operations

3.25

3.13

3.5

4.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2.96

3.13

1.4

3.4

—

Other disorders of lacrimal gland

2.47

3.12

5.2

1.9

—

Bacterial, viral and other infectious agents

3.67

3.08

4.9

3.4

—

Dental caries, including avohilmo

102

1.91

3.07

3.2

2.1

—

Idiopathic thrombocytopenic purpura

7.53

3.05

4.8

6.1

—

Benign neoplasm of major salivary glands

7.51

3.05

1.5

1.3

—

Crohn's disease of small intestine

5.01

3.05

1.9

4.4

—

Ulcer of lower limb, not elsewhere classified

5.00

3.05

1.0

2.2

—

Diseases of the musculoskeletal system and connective tissue

148

1.73

3.04

4.0

3.7

—

Ischaemic heart disease, wide definition

100

1.98

3.03

1.8

1.2

—

Ulcerative colitis (strict definition, require KELA)

2.89

3.02

1.4

3.3

—

Conjunctivitis (acute, non atopic)

146

1.98

3.00

2.9

4.0

—

Dilated cardiomyopathy

4.29

2.99

2.7

2.9

—

Polyuria

3.55

2.98

1.3

1.9

—

Other disorders of urethra and urinary system

134

1.89

2.98

2.5

2.7

—

Drug-induced adrenocortical insufficiency

10.06

2.98

3.2

4.4

—

Acquired haemolytic anaemia

10.04

2.98

2.8

4.2

—

Intestinal malabsorption

10.02

2.98

3.2

4.0

—

Scleritis and episcleritis

10.02

2.98

1.0

1.4

—

Benign neoplasm: Parotid gland

10.01

2.98

1.6

1.0

—

Infections with a predominantly sexual mode of transmission

2.40

2.95

2.9

1.8

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

5.15

2.93

1.3

1.9

—

COPD (mode)

3.93

2.93

1.0

1.2

—

Collagenous colitis

4.71

2.91

1.0

3.5

—

Cholelithiasis, broad definition with cholecystitis

116

1.91

2.90

2.5

1.5

—

Contact with and exposure to communicable diseases

155

1.93

2.89

4.3

3.3

—

Sequelae with surgical and medical care as external cause

3.44

2.89

2.7

2.6

—

Dysphagia

3.44

2.89

3.1

1.6

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

4.13

2.88

3.7

6.2

—

Other and unspecified local infections of skin and subcutaneous tissue

3.71

2.87

6.2

4.1

—

Phlebitis and thrombophlebitis (not including DVT)

3.71

2.87

1.8

1.9

—

Chronic pancreatitis

5.39

2.87

2.7

1.2

—

Other diseases of pancreas

6.68

2.86

1.2

1.7

—

Congenital absence, atresia and stenosis of large intestine

9.01

2.80

3.6

6.2

—

Mucosal proctocolitis

3.34

2.80

1.3

3.5

—

Unspecified haematuria

2.32

2.80

3.9

2.2

—

DVT of lower extremities

4.45

2.79

1.0

1.2

—

Early onset COPD, excluding more controls

3.91

2.77

1.0

1.1

—

Mycoses

239

1.67

2.77

2.1

2.6

—

Ill-defined and unknown causes of mortality

8.34

2.75

1.2

1.5

—

Parasetamol

128

1.74

2.73

4.0

2.5

—

Methotrexate

5.00

2.72

1.0

1.6

—

Migraine

157

1.81

2.71

3.7

3.1

—

Other local infections of skin and subcutaneous tissue

3.45

2.69

6.2

3.9

—

Atrophic disorders of skin

4.21

2.67

6.0

2.5

—

Other and unspecified urticaria

2.28

2.67

3.2

4.0

—

2.97

2.63

2.3

1.2

—

Symptoms and signs involving the urinary system

177

1.72

2.62

2.7

2.4

—

Congenital malformations of cardiac septa

2.13

2.62

4.6

5.0

—

Aortic aneurysm

3.68

2.61

2.6

1.1

—

Other condition

3.34

2.60

3.3

3.0

—

COPD-related respiratory insufficiency

4.67

2.59

1.0

1.1

—

Attention to artificial openings

7.16

2.55

4.4

4.7

—

Other and unspecified injuries of ankle and foot

5.47

2.54

2.3

3.1

—

Ingrowing nail

5.47

2.54

3.2

3.5

—

Disorders of parathyroid gland

3.56

2.54

2.6

1.6

—

Noninflammatory disorders of female genital tract

2.14

2.53

3.4

3.0

—

Migraine without aura and triptan purchases

2.60

2.52

6.2

2.5

—

Tonsillectomy and adenotomy

211

1.62

2.52

4.5

3.2

—

Congenital malformations of great veins

4.56

2.50

3.9

4.6

—

Depression

211

1.61

2.49

1.9

2.4

—

Weight loss

3.47

2.48

5.7

4.9

—

Erectile dysfunction

4.38

2.47

4.6

2.1

—

Abnormal findings on diagnostic imaging of other body structures

3.81

2.46

1.1

2.3

—

ILD, hospital admissions

3.81

2.46

1.3

1.7

—

Other interstitial pulmonary diseases

3.81

2.46

1.3

1.7

—

Interstitial lung disease endpoints

3.81

2.46

1.3

1.7

—

Interstitial lung disease

3.81

2.46

1.3

1.7

—

Chronic sinusitis

109

2.02

2.44

4.0

1.8

—

Neonatal jaundice from other and unspecified causes

2.22

2.44

7.6

5.3

—

Aortic valve malfunction, age under 60 years

3.13

2.43

2.9

4.1

—

Dental operations

2.05

2.43

4.3

1.2

—

Chronic gastritis

2.90

2.41

1.5

—

Other coagulation defects

5.01

2.40

2.8

4.0

—

Intestinal adhesions without obstruction

5.01

2.40

2.5

2.1

—

Complex cardiac defects

4.22

2.38

4.6

5.7

—

Iron deficiency

6.27

2.37

2.0

4.8

—

Vulvovaginal ulceration/inflammation in other diseases

6.26

2.37

5.6

2.3

—

Disorders of calcium metabolism

6.26

2.37

2.6

4.9

—

Benign neoplasm: salivary glands, exclude unknown (D119)

6.26

2.37

1.6

1.3

—

Acute lymphadenitis

4.13

2.36

5.4

4.8

—

Post-traumatic stress disorder

4.12

2.36

2.3

4.0

—

Hyperkinetic disorders

122

1.93

2.36

3.6

4.6

—

Diplopia

4.12

2.36

1.9

3.2

—

Presence of other functional implants

2.42

2.35

2.5

1.2

—

KRA_PSY_EATING, excluding more controls

3.62

2.35

2.9

2.8

—

Atopic dermatitis, strict definition with reimbursement

148

1.83

2.34

2.9

4.0

—

Impacted teeth

2.03

2.34

3.6

3.8

—

Distal bite

2.25

2.31

4.7

5.0

—

Impetigo

3.22

2.30

4.2

5.5

—

Other hearing loss

2.97

2.29

1.1

2.5

—

Viral infections of the central nervous system

4.62

2.27

3.8

2.5

—

Benign neoplasm: Transverse colon

4.62

2.27

1.3

1.2

—

Impacted maxillary molar

3.49

2.27

2.8

4.0

—

Colonic or urogenital fistula

2.55

2.26

3.7

2.0

—

Asthma, hospital admissions , main diagnosis only

285

1.55

2.26

2.7

2.9

—

Other diseases of urinary system

210

1.53

2.24

2.5

2.8

—

Follicular cysts of skin and subcutaneous tissue

3.11

2.22

1.3

1.7

—

Protein-energy malnutrition of moderate and mild degree

5.62

2.22

4.4

3.9

—

Viral infections of the central nervous system

5.56

2.21

4.2

2.2

—

Fracture of skull and facial bones

2.34

2.21

2.5

3.0

—

Other diseases of oesophagus

5.56

2.21

2.4

1.1

—

Cholelithiasis

111

1.80

2.20

2.3

1.5

—

Specific developmental disorder of motor function

2.35

2.19

5.0

5.6

—

Myopia

2.50

2.18

4.7

4.0

—

Female infertility

2.55

2.18

1.8

1.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.34

2.18

1.6

2.3

—

4.31

2.15

6.8

4.6

—

ILD, hospital admissions 1, main diag only

3.69

2.15

1.3

1.6

—

Gout, unspecified

3.69

2.15

2.0

1.0

—

Diabetic nephropathy

3.29

2.14

2.9

1.5

—

Gastroduodenal ulcer

2.99

2.13

2.7

1.3

—

Chondropathies

2.78

2.13

4.3

2.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.78

2.13

2.9

1.6

—

Skin changes due to chronic exposure to nonionizing radiation

2.79

2.13

2.6

1.2

—

Cardiac arrest

5.35

2.10

1.8

2.8

—

Exposure to other and unspecified inanimate mechanical forces

3.21

2.09

2.4

4.1

—

Disorders of speech understanding and production

2.21

2.08

4.3

5.3

—

Other and unspecified coagulation defects

5.01

2.07

1.8

4.1

—

Other ulcerative colitis

5.01

2.07

1.4

3.4

—

Pain in joint

114

1.73

2.07

2.1

2.7

—

Persons encountering health services for specific procedures, not carried out

5.00

2.07

1.2

3.2

—

Special screening examination for other diseases and disorders

5.00

2.07

5.0

1.3

—

Otitis externa, unspecified

2.71

2.06

6.5

4.2

—

Mood [affective] disorders

212

1.53

2.06

1.9

2.4

—

Other/unspecified synovitis and tenosynovitis

3.50

2.05

1.7

—

Mood disorders

212

1.53

2.05

1.9

2.4

—

Polycystic ovarian syndrome, consortium definition

1.77

2.04

2.0

1.9

—

Hyperparathyroidism

3.46

2.03

1.1

1.3

—

Hypothyroidism, drug reimbursement

4.24

2.02

2.8

2.6

—

Adalimumab

3.08

2.01

1.1

3.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

175

1.67

2.01

2.8

3.0

—

Fissure and fistula of anal and rectal regions

2.50

2.01

3.1

2.0

—

Coronary atherosclerosis

1.95

2.00

1.1

—

Disorders of lacrimal system

1.95

1.98

5.0

2.5

—

Other disorders of veins

2.21

1.98

1.4

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

177

1.56

1.97

2.4

3.4

—

Contraceptive management

1.81

1.96

2.6

1.6

—

Other diseases of lip and oral mucosa

112

1.88

1.95

3.2

2.7

—

Other arthritis (FG)

2.02

1.95

1.6

2.7

—

Neurological diseases

210

1.46

1.95

3.4

3.2

—

Disturbances of skin sensation

2.35

1.94

2.7

2.0

—

Viral agents as the cause of diseases classified to other chapters

4.57

1.94

5.0

4.3

—

Additional codes for the location of defect, injury or illness

4.55

1.94

1.6

4.2

—

Bronchiectasis

4.55

1.94

2.8

4.3

—

Rosacea

4.55

1.94

3.8

2.0

—

COPD, hospital admission 2, with asthma infections

2.60

1.93

1.0

1.5

—

Other Crohn's disease

3.76

1.93

1.2

4.3

—

Major coronary heart disease event excluding revascularizations

1.98

1.90

1.5

—

Angina pectoris

2.06

1.89

1.8

1.1

—

Codeine or tramadol medication

160

1.54

1.88

1.8

1.4

—

Cerebral palsy and other paralytic syndromes

2.65

1.86

2.7

4.3

—

Other gastritis (incl. Duodenitis)

2.65

1.86

1.2

2.0

—

Other benign neoplasms of skin

2.08

1.86

2.0

2.2

—

Atrial septal defect

2.15

1.85

4.4

4.9

—

Hordeolum and other deep inflammation of eyelid

3.54

1.83

4.3

4.2

—

Bell's palsy

3.53

1.83

5.0

1.8

—

Gout, strict definition

3.53

1.83

1.0

—

Intermittent heterotropia

2.21

1.83

5.4

5.1

—

All anxiety disorders

167

1.61

1.83

4.2

2.2

—

Viral agents as the cause of diseases classified to other chapters

4.18

1.82

5.0

4.0

—

L04AC Interleukin inhibitors

4.17

1.82

1.2

3.9

—

Osteomyelitis

4.17

1.82

1.8

4.8

—

Seronegative rheumatoid arthritis

4.17

1.82

1.0

1.1

—

Intracerebral haemorrhage

4.17

1.82

3.6

2.0

—

Hernia of abdominal wall

115

1.83

1.82

1.9

2.2

—

Migraine with aura

2.06

1.80

2.8

2.9

—

Pain associated with micturition

3.05

1.80

1.9

3.3

—

Other (seronegative) rheumatoid arthritis, wide

3.05

1.79

1.1

1.5

—

Infectious mononucleosis

2.76

1.79

3.4

3.5

—

Malignant neoplasm of skin

2.23

1.75

1.1

1.3

—

Congenital deformities of feet

3.34

1.74

2.5

5.5

—

Motor disorders

2.10

1.74

5.0

5.7

—

Pediculosis, acariasis and other infestations

3.34

1.74

5.5

2.9

—

Otitis externa

2.03

1.74

5.4

3.3

—

Diabetic nephropathy, excluding more controls

2.74

1.74

2.9

1.5

—

Dementia, including avohilmo

0.00

1.73

0.0

1.3

—

Other disorders of optic [2nd] nerve and visual pathways

2.92

1.72

2.7

4.3

—

Dorsalgia

182

1.47

1.72

1.8

2.3

—

Radiculopathy

2.92

1.72

1.7

1.4

—

Benign neoplasm of other and ill-defined parts of digestive system

2.92

1.72

1.1

1.6

—

Pneumonia derived septicemia

3.86

1.71

5.0

5.5

—

Scabies

3.85

1.71

6.4

3.6

—

Anogenital herpesviral [herpes simplex] infection

3.85

1.71

1.6

2.2

—

Biological medication for rheuma

2.13

1.71

1.5

4.2

—

Umbilical hernia

2.06

1.70

1.7

2.0

—

Benign neoplasm: Colon

1.96

1.69

1.3

1.2

—

Female infertility, cervical, vaginal, other or unspecified origin

2.39

1.68

1.6

1.3

—

Colorectal cancer

3.76

1.68

2.8

1.2

—

Menorrhagia

2.16

1.68

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.26

1.67

1.0

1.3

—

Misadventures to patients during surgical and medical care

3.16

1.66

3.0

2.4

—

Recurrent or chronic depression

1.80

1.66

1.9

1.4

—

Other disorders of glucose regulation and pancreatic internal secretion

2.58

1.66

3.3

4.7

—

Atrial fibrillation and flutter with reimbursement

2.68

1.63

1.3

1.4

—

Other specified/unspecified hearing loss

3.57

1.61

1.0

4.0

—

Heart failure and bmi 25plus

2.41

1.60

1.6

1.1

—

Disorders of optic nerve and visual pathways

2.50

1.59

2.5

3.7

—

Hydrocele

2.50

1.59

3.5

3.3

—

Acute and subacute iridocyclitis

2.50

1.59

1.1

2.6

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.53

1.59

1.0

1.4

—

Coarctation of the aorta

3.03

1.58

5.0

6.3

—

Conductive hearing loss, unspecified

3.00

1.58

7.5

4.9

—

Lung diseases due to external agents

3.00

1.58

2.2

2.5

—

Other and unspecified injuries of lower leg

2.70

1.58

2.1

3.4

—

Seropositive rheumatoid arthritis

2.68

1.57

1.6

1.1

—

Hypopituitarism

2.20

1.56

4.2

4.5

—

Chronic periodontitis, complicated

113

1.75

1.55

2.0

1.3

—

Dementia

0.00

1.55

0.0

1.3

—

Other antidepressants

157

1.47

1.54

1.5

2.1

—

Migraine without aura

1.88

1.54

5.7

3.7

—

Allergic asthma (mode), excluding more controls

2.64

1.54

3.9

2.8

—

Congenital deformities of feet

3.34

1.52

2.8

6.1

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.34

1.52

1.8

3.5

—

Crohn disease (strict definition, require KELA)

3.34

1.52

1.8

3.5

—

Gout, idiopatic and unspecified

2.59

1.51

2.0

1.1

—

STROKE

1.72

1.51

2.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.86

1.50

1.0

2.0

—

Retinal detachments and breaks

2.16

1.50

1.9

1.3

—

Respiratory and cardiovascular disorders specific to the perinatal period

103

1.75

1.50

4.9

5.3

—

Anxiety (asthma-related co-morbidities)

173

1.52

1.49

4.2

2.5

—

Cardiac murmurs and other cardiac sounds

1.95

1.49

4.9

4.6

—

Anterior Iridocyclitis

2.43

1.47

1.2

2.7

—

Early onset COPD

2.43

1.47

1.0

1.4

—

Other arrhythmias

127

1.60

1.47

1.5

2.5

—

Other systemic involvement of connective tissue (FG)

2.40

1.46

2.1

2.4

—

Epilepsy

147

1.63

1.45

2.2

3.8

—

Hypoglycaemia, other or unspecified

2.50

1.45

3.6

4.9

—

Disorders of thyroid, IBD co-morbidities

2.59

1.45

1.4

3.9

—

Myocardial infarction

1.97

1.44

1.5

1.3

—

Vocal cord dysfunction

2.51

1.44

2.7

2.5

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.13

1.44

1.8

3.4

—

Eustachian salpingitis and obstruction

3.13

1.44

5.2

3.2

—

Plantar fascial fibromatosis

3.13

1.44

2.2

1.5

—

Benign neoplasm: Ascending colon

3.13

1.44

1.4

1.2

—

Biguanides

156

0.55

1.43

1.4

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.40

1.43

1.2

1.8

—

Thyroiditis, ILD-related definition

2.73

1.43

1.3

3.4

—

Cystitis

167

1.46

1.43

2.1

2.8

—

Strabismus

140

1.64

1.43

5.3

3.8

—

Disorders of conjunctiva

275

1.40

1.42

2.7

3.1

—

Disease of hard tissues of teeth, NOS

1.85

1.40

3.7

1.1

—

Eating disorders

2.25

1.39

2.7

3.6

—

Other specified/unspecified arthritis

1.85

1.39

1.6

3.0

—

Other anxiety disorders

122

1.63

1.39

4.7

2.3

—

COPD

1.97

1.38

1.3

—

Insulin medication

179

1.50

1.37

2.8

3.0

—

Coeliac disease

2.20

1.36

1.4

5.0

—

Crohn's disease NAS

2.61

1.36

2.2

6.0

—

Abnormal weight loss

2.61

1.36

2.3

4.6

—

Arthropathies

207

1.37

1.36

2.2

3.3

—

Basal cell carcinoma

2.22

1.36

1.0

1.2

—

Other strabismus

119

1.68

1.35

5.5

4.2

—

Generalized anxiety disorder

2.14

1.33

2.7

2.5

—

Other systemic involvement of connective tissue

2.14

1.33

2.1

2.3

—

Use of hypnotics and sedatives

183

1.41

1.33

2.0

2.2

—

COPD, hospital admissions 1, only main diagnosis

2.14

1.32

1.0

1.3

—

Inguinal hernia

121

1.55

1.32

3.6

2.4

—

Disorders of sclera, cornea, iris and ciliary body

160

1.56

1.31

3.4

2.2

—

Dizziness and giddiness

164

1.50

1.30

2.4

2.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.68

1.29

1.3

—

Exposure to unspecified factor

288

1.35

1.28

3.3

2.8

—

Other keratitis

2.78

1.28

8.4

2.9

—

Iridocyclitis

2.08

1.27

1.2

2.9

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.09

1.26

3.8

2.1

—

Congenital malformations of cardiac chambers and connections

2.44

1.25

5.0

6.3

—

Actinic keratosis

2.24

1.24

3.0

1.2

—

Haemangioma, any site

2.40

1.24

3.2

3.6

—

Infections with a predominantly sexual mode of transmission

114

1.63

1.24

2.7

2.0

—

Seborrhoeic keratosis

2.40

1.24

1.5

1.2

—

Fracture of lumbar spine and pelvis

2.40

1.24

2.5

1.6

—

Diagnoses used for exclusion with ILD

2.00

1.23

1.8

2.3

—

Amenorrhoea

2.63

1.21

2.0

3.1

—

Other symptoms and signs involving the urinary system

2.63

1.21

1.4

2.3

—

Ventral hernia

2.16

1.21

2.0

1.7

—

Diseases of external ear

116

1.64

1.21

5.1

3.5

—

Other specific joint derangements/joint disorders

184

1.40

1.20

2.0

3.0

—

Conjunctivitis

268

1.37

1.20

2.8

3.1

—

Other disorders of ear

220

1.37

1.20

3.2

2.7

—

Other noninflammatory disorders of uterus, except cervix

0.00

1.20

0.0

1.3

—

Childhood allergy (age < 16)

141

1.52

1.19

2.4

5.0

—

Artrosis, including avohilmo

139

0.59

1.19

1.2

1.4

—

Complications of labour and delivery

0.50

1.19

2.0

1.6

—

Conduction disorders

1.91

1.19

2.7

4.4

—

Stroke, excluding SAH

1.65

1.18

2.2

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.08

1.18

1.0

1.3

—

Social phobias

2.31

1.18

3.5

3.6

—

Focal epilepsy, strict definition

1.74

1.18

2.3

4.5

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.11

1.18

1.4

3.7

—

Eating disorder

2.10

1.18

2.9

3.7

—

Congenital malformations of great arteries

1.84

1.18

4.9

5.3

—

Fall involving playground equipment

0.00

1.16

0.0

5.8

—

Injuries to the ankle and foot

265

1.38

1.15

3.6

2.7

—

Amblyopia ex anopsia

2.06

1.15

4.8

6.1

—

Foreign body in respiratory tract

2.50

1.15

4.2

3.8

—

Mixed conductive and sensorineural hearing loss

2.50

1.15

1.2

2.9

—

COPD related to multimorbidity

2.01

1.14

1.0

1.3

—

Pain in limb

222

1.36

1.12

3.5

2.9

—

Diabetes, varying definitions

214

1.34

1.12

2.7

—

Persons encountering health services in other circumstances

118

1.60

1.12

3.1

2.8

—

Allergic asthma (mode)

2.28

1.11

3.9

2.7

—

Disorders of puberty, all

2.27

1.10

3.7

7.1

—

Chronic diseases of tonsils and adenoids

232

1.33

1.10

3.2

2.8

—

Rheumatoid arthritis

1.90

1.10

1.5

1.4

—

Episodal and paroxysmal disorders

257

1.29

1.09

2.7

3.1

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.39

1.09

9.8

7.4

—

Helminthiases

2.38

1.09

1.0

4.5

—

Abnormal results of function studies

2.38

1.09

2.0

5.4

—

Abscess of anal and rectal regions

2.38

1.09

2.6

3.8

—

Perforation of tympanic membrane

2.38

1.09

3.8

3.4

—

Other superficial mycoses

2.38

1.09

1.0

3.1

—

Orchitis and epididymitis

2.38

1.09

2.6

2.5

—

Myocardial infarction, strict

1.86

1.09

1.6

1.3

—

Heterophoria

1.95

1.08

5.3

5.1

—

Coronary artery bypass grafting

2.17

1.06

1.1

1.2

—

Superficial injury of forearm

2.12

1.05

5.0

4.9

—

Paracetamol or NSAID medication

0.50

1.04

9.7

4.6

—

Conductive and sensorineural hearing loss

158

1.41

1.04

3.8

2.6

—

Benign paroxysmal vertigo

1.96

1.03

1.0

1.7

—

Mixed specific developmental disorders

1.75

1.03

3.9

5.4

—

Other soft tissue disorders, not elsewhere classified

238

1.31

1.03

3.3

3.0

—

Basal cell carcinoma, including avohilmo

1.94

1.02

1.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.83

1.02

2.7

2.1

—

Mandibular retrognathia

1.91

1.01

6.9

4.7

—

Disorders of breast

1.63

1.01

2.3

1.6

—

Spondylopathies

122

0.59

1.01

1.3

1.8

—

Acne

1.89

1.00

3.7

4.3

—

Fibroblastic disorders

2.00

1.00

2.1

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

151

1.48

0.99

2.3

1.9

—

Chalazion

2.18

0.98

2.2

2.8

—

Colectomy operation

2.17

0.98

3.0

1.8

—

Benign neoplasm: Rectum

2.17

0.98

1.2

—

Any dementia

0.00

0.98

0.0

1.4

—

Any dementia, excluding more controls

0.00

0.97

0.0

1.4

—

Gonarthrosis

0.54

0.97

1.1

1.3

—

Unspecific neurodegenerative disorder

0.00

0.97

0.0

1.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.95

0.97

1.6

1.1

—

Other/unspecified seropositive rheumatoid arthritis

1.95

0.97

1.6

1.1

—

Seropositive rheumatoid arthritis, wide

1.95

0.97

1.6

1.1

—

Other chronic obstructive pulmonary disease

1.81

0.97

1.0

1.3

—

Other and unspecified effects of external causes

116

1.55

0.96

2.6

3.5

—

Injuries to the thorax

108

1.57

0.96

1.5

2.1

—

Diabetes mellitus

215

1.30

0.95

3.0

2.6

—

Atopic dermatitis, strict definition

187

1.41

0.94

3.0

4.1

—

Persistent mood disorders

1.89

0.94

1.6

2.5

—

COPD, hospital admissions

1.79

0.93

1.0

1.4

—

Focal epilepsy

101

1.58

0.93

2.3

4.7

—

COPD, early/later onset

1.78

0.93

1.0

1.4

—

Atopic dermatitis

198

1.37

0.92

2.8

3.3

—

Maternal care for known or suspected fetal abnormality and damage

2.15

0.91

1.2

1.4

—

Varicose veins

1.62

0.91

1.3

1.2

—

Adverse effects, not elsewhere classified

1.63

0.90

3.0

3.7

—

Disorders of eyelid, lacrimal system and orbit

204

1.34

0.89

4.1

2.3

—

Haemangioma and lymphangioma, any site

2.07

0.89

3.2

3.5

—

Coxarthrosis [arthrosis of hip](FG)

1.59

0.89

1.3

1.1

—

Open wound of wrist and hand

166

0.59

0.89

2.4

—

Nasal polyp

1.91

0.88

2.5

1.3

—

Soft tissue disorders

246

1.26

0.88

3.2

3.1

—

Gastro-oesophageal reflux disease

174

1.39

0.88

2.0

2.7

—

Tumor necrosis factor alpha inhibitors

1.79

0.87

1.5

3.9

—

Chronic lower respiratory diseases

274

1.24

0.87

2.6

3.0

—

Keratitis

1.58

0.87

4.9

2.4

—

Coxarthrosis

1.58

0.86

1.3

—

Acute nasopharyngitis (common cold)

1.99

0.86

1.0

2.1

—

Cerebrovascular diseases

118

1.43

0.85

2.7

1.8

—

Fracture of femur

1.81

0.85

4.0

2.5

—

Stroke, including SAH

1.50

0.85

2.2

1.8

—

Bacterial sepsis of newborn

1.96

0.85

4.3

6.3

—

Allergic urticaria

1.94

0.84

11.3

5.5

—

Other disorders of eye and adnexa

1.78

0.84

9.0

4.1

—

Functional dyspepsia

1.78

0.84

1.3

1.7

—

Septal defects

102

1.54

0.83

4.5

5.2

—

Superficial injury of ankle and foot

1.76

0.83

3.0

3.6

—

Alcohol dependence

1.75

0.83

1.3

1.4

—

Alcohol use disorder, Swedish definition

133

1.45

0.83

1.7

1.9

—

Sleep disorders (combined)

224

0.75

0.83

1.6

2.6

—

Intracranial injury

236

0.68

0.82

4.0

3.0

—

Somatoform disorder

1.88

0.81

1.5

2.2

—

Ovarian cyst

1.69

0.81

2.7

1.6

—

Diseases of inner ear

102

1.52

0.79

1.3

1.6

—

Other infections specific to the perinatal period

0.00

0.79

0.0

6.0

—

Early lumbar disc prolapse, operated

0.00

0.79

0.0

1.8

—

Other retinal disorders

101

1.47

0.79

1.9

2.4

—

Ischaemic Stroke, excluding all haemorrhages

1.55

0.78

1.8

—

Benign lipomatous neoplasm

1.67

0.78

1.4

1.9

—

Degenerative diseases of the nervous system

0.00

0.78

0.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.66

0.78

1.4

2.0

—

152

1.39

0.78

2.5

2.1

—

Myocardial infarction, without ST-elevation

1.66

0.78

1.0

1.1

—

Sciatica+with lumbago

113

1.47

0.77

1.3

1.4

—

Juvenile arthritis (FINNGEN)

1.77

0.76

3.0

6.2

—

Malignant neoplasm of prostate, including Hilmo

2.12

0.75

1.0

1.1

—

Psoriasis

1.64

0.75

3.5

2.1

—

Disorders of puberty

2.09

0.74

3.8

6.6

—

Other nutritional deficiencies

205

1.33

0.74

2.4

—

Superficial injury of thorax

2.08

0.74

1.2

2.1

—

Other obstetric conditions, not elsewhere classified

1.62

0.73

1.4

1.9

—

Psoriasis vulgaris

1.84

0.73

3.9

2.5

—

Disorders of choroid and retina

142

1.35

0.73

1.8

2.0

—

Respiratory distress of newborn

1.54

0.73

5.1

5.4

—

Insulin, fast-acting

133

1.43

0.73

3.4

3.6

—

Mouth breathing

184

1.36

0.73

3.6

3.5

—

Hyperlipidaemia, other/unspecified

1.62

0.73

1.7

1.5

—

Abnormalities of heart beat

1.59

0.73

2.5

2.0

—

Appendectomy

176

1.36

0.73

1.1

1.9

—

Salpingitis and oophoritis

2.00

0.72

2.0

1.2

—

Nontraumatic intracranial haemmorrhage

2.00

0.72

3.6

2.0

—

Embedded teeth, including avohilmo

1.80

0.72

3.0

5.0

—

Sulfasalazine

1.80

0.72

1.0

1.3

—

Visual disturbances and blindness

176

1.36

0.72

2.9

3.0

—

Visual disturbances

159

1.38

0.72

2.9

3.0

—

Isolated growth hormone deficiency

1.77

0.72

4.6

5.8

—

Congenital malformations and deformations of the musculoskeletal system

108

1.48

0.71

4.1

4.5

—

Sensorineural hearing loss

142

1.34

0.71

3.1

2.6

—

Chronic suppurative otitis media, including avohilmo

1.75

0.71

3.9

4.7

—

Benign neoplasm: Rectum, anus and anal canal

1.92

0.70

1.2

—

Unstable angina pectoris

1.73

0.70

1.0

1.2

—

Other/unspecified dorsalgia

1.51

0.69

3.1

2.3

—

Congenital malformations of pulmonary and tricuspid valves

1.87

0.69

4.4

6.1

—

Asthma (diagnoses ohter than nonallergic)

286

1.25

0.68

2.6

2.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

216

1.26

0.68

2.1

2.3

—

Congenital malformations of the nervous system

1.86

0.68

1.6

5.5

—

Other eating disorders

1.85

0.68

3.2

4.2

—

Allergic colitis

1.64

0.68

3.8

5.0

—

Spondylosis

0.58

0.68

1.3

1.4

—

Spontaneous abortion

0.52

0.68

2.0

1.3

—

Other diseases of upper respiratory tract

235

1.22

0.67

3.7

2.8

—

Congenital malformations and deformations of the musculoskeletal system

118

1.43

0.67

3.9

4.4

—

Infections specific to the perinatal period

1.64

0.67

4.3

5.8

—

Non-allergic asthma

1.63

0.66

3.6

4.8

—

Gonarthrosis,primary

126

0.68

0.66

1.1

1.3

—

Kela-code for severe mental illness

0.53

0.66

2.4

1.6

—

Use of pramipexole

1.79

0.66

1.2

1.3

—

Other congenital malformations of tongue, mouth and pharynx

1.78

0.66

4.2

5.7

—

Substance abuse, excluding more controls

116

1.40

0.65

2.5

1.5

—

Acne vulgaris

1.59

0.65

3.6

4.5

—

Migraine with aura and triptan purchases

1.59

0.65

2.9

—

Rheumatoid arthritis, including avohilmo

1.57

0.65

1.5

1.4

—

Ventricular septal defect, a heart condition

1.61

0.64

7.3

5.4

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.54

0.64

4.8

5.2

—

Temporomandibular joint disorders, including avohilmo

119

1.41

0.62

1.8

2.4

—

Alzheimer disease, excluding more controls

0.00

0.62

0.0

1.2

—

148

1.34

0.61

2.3

2.0

—

Congenital malformations of the respiratory system

1.67

0.61

8.8

5.3

—

Congenital malformations of the respiratory system

1.67

0.61

8.8

5.3

—

Other inflammation of eyelid

1.67

0.61

9.2

3.1

—

Leiomyoma of uterus

1.47

0.61

1.3

—

Inflammatory diseases of female pelvic organs

101

1.38

0.61

3.3

1.8

—

Insomnia

204

0.75

0.61

2.0

2.2

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.61

0.0

4.5

—

Alzheimer disease, including avohilmo

0.00

0.61

0.0

1.2

—

Carpal tunnel syndrome

121

0.66

0.61

1.4

1.2

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.61

0.0

4.4

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.52

0.61

4.8

5.1

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.60

0.0

5.1

—

Metatarsalgia

0.00

0.60

0.0

1.9

—

N06DA Anticholinesterases

0.00

0.60

0.0

1.2

—

Use of anticholinesterases

0.00

0.60

0.0

1.2

—

Insulin, fast-acting or short human

139

1.37

0.60

3.4

3.6

—

Low back pain

162

1.29

0.59

1.1

2.1

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.59

0.0

1.9

—

Diseases of male genital organs

131

1.27

0.59

3.3

3.2

—

Papulosquamous disorders

1.44

0.58

2.9

2.0

—

Disorders of vestibular function (Vertigo)

1.49

0.58

1.1

1.5

—

Unspecified mental disorder

112

0.62

0.58

2.0

1.7

—

Primary coxarthrosis, bilateral

1.71

0.57

1.3

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

225

0.81

0.57

1.4

3.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.46

0.56

1.8

1.4

—

Other maternal disorders predominantly related to pregnancy

0.67

0.56

1.9

1.6

—

Other juvenile arthritis

1.62

0.55

3.0

5.8

—

External causes of morbidity and mortality

145

1.24

0.55

3.6

2.7

—

Glucosamine medication

1.53

0.55

1.1

—

Hypertensive heart and/or renal disease

1.60

0.55

5.5

1.8

—

Acetic acid derivatives and related substances

0.59

0.54

3.2

2.2

—

Coxarthrosis, primary, with hip surgery

1.50

0.54

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.58

0.54

1.2

2.6

—

Panic disorder

1.58

0.54

2.2

2.3

—

Hypertrophy of breast in women and men

1.58

0.54

2.5

1.9

—

Medical treatment for female infertility

1.57

0.54

2.2

1.5

—

Atrial septal defect, secundum type

1.47

0.53

4.6

5.3

—

Calculus of kidney and ureter

1.48

0.53

2.3

2.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

125

1.36

0.53

3.2

3.5

—

Lower back pain or/and sciatica

197

1.23

0.53

1.2

2.1

—

Sleep disorders

213

0.78

0.52

1.9

2.3

—

Type 2 diabetes, definitions combined

140

1.26

0.52

1.4

—

Injuries to the elbow and forearm

243

1.23

0.52

3.5

2.8

—

Cholecystectomy

123

1.33

0.52

1.5

—

Non-selective monoamine reuptake inhibitors

1.42

0.52

1.1

—

Type 2 diabetes

151

1.24

0.49

1.8

1.5

—

Postmenopausal bleeding

1.56

0.49

1.0

1.3

—

Allergic conjunctivitis

207

0.75

0.49

3.6

2.9

—

Artificial joint operation, meniscal resection

146

0.76

0.49

1.1

1.5

—

Chronic rhinitis, nasopharyngitis and pharyngitis

108

0.65

0.48

1.3

3.0

—

Fracture of foot, except ankle

1.45

0.48

4.6

2.8

—

Type 2 diabetes, strict (exclude DM1)

142

1.24

0.48

1.4

1.3

—

Open wound of lower leg

1.49

0.47

2.7

4.0

—

Mental retardation, excluding more controls

1.48

0.47

5.3

5.2

—

Alcohol use disorder, ICD-based

102

1.37

0.47

1.6

1.7

—

Other menopausal disorders

1.46

0.47

1.0

1.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.42

0.45

1.1

1.2

—

Disorders of synovium and tendon

136

1.29

0.45

3.8

1.8

—

Other neurological diseases

143

1.26

0.45

2.3

—

Necrosis of pulp, including avohilmo

186

0.75

0.44

1.4

2.1

—

Diabetic retinopathy, excluding more controls

1.45

0.43

2.6

1.9

—

Overjet

1.45

0.43

7.0

5.5

—

Injuries to the head

296

0.85

0.43

2.6

2.9

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.61

0.43

2.4

4.3

—

Injury of muscle and tendon at wrist and hand level

1.61

0.43

1.0

2.5

—

Other dorsopathies, not elsewhere classified

186

1.18

0.43

2.1

2.4

—

Nonorganic sleeping disorders, excluding more controls

1.43

0.42

2.9

2.2

—

Fracture of rib(s), sternum and thoracic spine

1.43

0.42

1.9

—

Injuries to unspecified part of trunk, limb or body region

1.56

0.42

3.8

4.1

—

Other respiratory conditions originating in the perinatal period

0.00

0.42

0.0

5.4

—

Intracranial trauma

177

0.79

0.42

3.5

3.0

—

Parkinson's disease, excluding more controls

0.00

0.41

0.0

1.7

—

Spondylolisthesis/Spondylolysis

1.52

0.41

1.0

1.5

—

Subarachnoid haemorrhage

0.00

0.41

0.0

2.6

—

Infections of genitourinary tract in pregnancy

0.00

0.41

0.0

1.6

—

Disorders of muscles

0.00

0.41

0.0

2.4

—

Injuries to the neck

1.36

0.41

1.3

2.7

—

Other functional intestinal disorders

172

1.24

0.40

4.0

3.8

—

Stenosis and insufficiency of lacrimal passages

0.00

0.40

0.0

3.3

—

Cervicocranial syndrome

0.00

0.40

0.0

1.9

—

Other (not insulin) diabetes medications

149

0.80

0.40

1.5

1.4

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1.39

0.40

2.0

4.5

—

Medical abortion

1.28

0.40

1.5

1.9

—

Hypertrophy of breast

1.47

0.40

2.8

1.9

—

Endometriosis ASRM stages 3,4

1.47

0.40

1.6

—

Alzheimer disease

0.00

0.40

0.0

1.1

—

Personality disorders, excluding more controls

1.33

0.40

1.6

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.40

0.0

6.2

—

Contact with machinery

0.00

0.40

0.0

2.1

—

Early lumbar disc prolapse operation

0.00

0.40

0.0

1.9

—

Abnormal involuntary movements

1.43

0.39

1.2

3.5

—

Pre-eclampsia

1.43

0.39

1.2

1.4

—

Type 1 diabetes, wide definition

105

0.67

0.39

3.7

4.1

—

Other congenital malformations of tongue, mouth and pharynx

1.42

0.39

4.2

5.2

—

Parkinson's disease

0.00

0.39

0.0

1.5

—

Parkinson's disease, including avohilmo

0.00

0.39

0.0

1.5

—

Injury, poisoning and certain other consequences of external causes

120

1.21

0.38

3.9

2.8

—

Scissor bite

1.37

0.38

5.1

5.3

—

Superficial injury of lower leg

1.38

0.38

3.1

3.3

—

Urolithiasis

1.36

0.38

2.3

2.2

—

Pedal cyclist injured in noncollision transport accidents

1.39

0.38

2.0

4.1

—

Calcific aortic valvular stenosis

1.38

0.38

1.2

2.0

—

Calcific aortic valvular stenosis, operated

1.38

0.38

1.2

2.0

—

Gonarthrosis [arthrosis of knee](FG)

0.75

0.37

1.1

—

Triptan medication for migraine, min. 3 purchases

129

1.24

0.37

3.2

2.3

—

Dorsopathies

212

1.15

0.37

2.2

2.8

—

Chronic apical periodontitis

190

1.17

0.37

1.2

2.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.35

0.37

1.0

1.8

—

HSIL lesion of the cervix uteri, vagina or vulva

1.35

0.37

2.0

1.4

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

115

0.70

0.37

2.4

3.1

—

Depression or dysthymia

108

1.23

0.36

2.1

1.8

—

False labour

0.62

0.36

1.6

1.9

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

1.29

0.36

4.2

3.5

—

Other arthrosis

0.72

0.36

1.2

1.3

—

Sequelae of cerebrovascular disease

1.44

0.35

2.2

1.5

—

Poisoning by medicine

0.66

0.35

1.6

2.6

—

Abrasion of teeth

0.63

0.35

1.0

1.8

—

Injuries to the wrist and hand

282

0.86

0.35

2.6

2.8

—

Maternal care for other conditions predominantly related to pregnancy

1.40

0.35

1.5

—

Gestational [pregnancy-induced] hypertension

1.39

0.35

1.3

—

Superficial injury of abdomen, lower back and pelvis

1.36

0.34

2.8

4.0

—

Thyrotoxicosis

1.36

0.34

1.5

2.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

108

1.29

0.34

1.6

1.7

—

Conotruncal defects

1.34

0.34

4.5

5.6

—

Disorders of lipoprotein metabolism and other lipidaemias

106

1.23

0.33

1.4

1.8

—

Other joint disorders

198

1.15

0.33

2.2

3.3

—

Redundant prepuce, phimosis and paraphimosis

1.36

0.32

4.9

2.6

—

Fetus and newborn affected by maternal complications of pregnancy

1.28

0.32

5.3

5.7

—

Type 2 diabetes, definitions combined, including avohilmo

143

1.18

0.32

1.4

1.3

—

Type 1 diabetes, definitions combined

1.35

0.32

3.4

5.1

—

Polyp of the female genital tract

1.34

0.31

1.3

1.6

—

Constipation

242

1.14

0.31

2.8

3.1

—

Asthma, including avohilmo

281

1.12

0.31

2.4

2.9

—

Other disorders originating in the perinatal period

1.35

0.31

3.7

5.4

—

Enthesopathies of lower limb, excluding foot

1.35

0.31

1.4

1.9

—

Long labour

1.33

0.31

1.1

1.3

—

Peripheral artery disease

1.33

0.31

1.1

1.4

—

Fall on same level

279

1.12

0.30

2.9

—

Effects of foreign body entering through natural orifice

102

1.27

0.30

3.5

3.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

180

0.81

0.30

3.1

3.0

—

Type 1 diabetes

111

1.26

0.29

3.8

3.9

—

Obesity and other hyperalimentation

199

0.82

0.29

1.4

2.4

—

Obesity

199

0.82

0.29

1.4

2.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.28

0.29

1.7

1.5

—

Diabetic retinopathy

1.28

0.28

2.6

1.8

—

Fall on same level involving ice and snow

173

0.81

0.28

3.1

2.3

—

Burns and corrosions

1.29

0.28

1.9

4.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

102

1.26

0.27

2.5

2.9

—

Specific personality disorders

1.23

0.27

1.6

2.1

—

Other spirochaetal diseases

1.23

0.27

2.4

2.5

—

Nonorganic sleeping disorders

1.21

0.26

2.9

—

Other spirochaetal diseases

1.21

0.26

2.4

2.5

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

160

0.84

0.26

2.0

2.2

—

Organic, including symptomatic, mental disorders

0.70

0.26

1.0

1.5

—

Dermatophytosis

182

0.82

0.26

1.9

2.4

—

Dental pulpitis, including avohilmo

209

0.87

0.26

1.1

2.3

—

Gestational diabetes (for exclusion)

1.31

0.26

1.4

1.6

—

Injuries to the shoulder and upper arm

241

0.87

0.25

2.7

2.6

—

Symptoms and signs involving the nervous and musculoskeletal systems

207

1.16

0.24

3.9

3.1

—

Pediculosis, acariasis and other infestations

1.18

0.24

4.8

3.9

—

Coxarthrosis, primary

1.25

0.24

1.2

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.70

0.24

5.3

5.2

—

Fracture at wrist and hand level

136

0.81

0.23

3.4

2.7

—

Corneal ulcer

1.32

0.23

1.8

2.7

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.32

0.23

1.2

1.9

—

Pre-eclampsia or eclampsia

1.32

0.23

1.2

1.4

—

Dysplasia of cervi uteri

1.29

0.23

2.0

1.3

—

Fracture of lower leg, including ankle

177

0.84

0.22

3.7

2.2

—

Primary gonarthrosis, bilateral

0.76

0.22

1.1

1.2

—

Thyrotoxicosis, other and/or unspecified

1.25

0.22

1.6

2.3

—

Tinnitus

1.25

0.22

1.4

—

Periapical abscess

157

0.83

0.22

1.2

2.7

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.22

0.0

1.3

—

Other perinatal haematological disorders

0.00

0.21

0.0

6.4

—

Disorders of muscle tone of newborn

0.00

0.21

0.0

4.9

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.20

0.21

2.5

1.4

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.21

0.0

3.2

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

5.1

—

Lung cancer and mesothelioma

0.00

0.21

0.0

1.2

—

Hypospadias

0.00

0.21

0.0

5.2

—

Other congenital malformations of kidney

0.00

0.21

0.0

5.3

—

Patent foramen ovale

1.19

0.21

5.0

5.5

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.21

0.0

1.9

—

Malignant neoplasm of bronchus and lung

0.00

0.21

0.0

1.9

—

Alzheimer’s disease, strict definition

0.00

0.21

0.0

1.1

—

Ankyloglossia

1.19

0.21

4.2

5.9

—

Toxic effect of contact with venomous animals

0.00

0.21

0.0

3.6

—

Failed induction of labour

0.00

0.21

0.0

1.6

—

Nontoxic single thyroid nodule

0.00

0.21

0.0

2.0

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.1

—

Pleural plaque

0.00

0.21

0.0

1.0

—

Primary hyperparathyroidism

0.00

0.21

0.0

1.4

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.9

—

Other chronic obstructive pulmonary disease, including avohilmo

1.24

0.21

1.0

1.3

—

Other congenital malformations of ear

0.00

0.21

0.0

5.9

—

Foreign body or object entering through skin

0.00

0.21

0.0

2.2

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.7

—

Sequelae of injuries of lower limb

0.00

0.21

0.0

1.4

—

Pollen allergy

154

0.83

0.21

1.8

4.4

—

Traumatic subdural haemorrhage

0.00

0.21

0.0

1.8

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.21

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

183

0.86

0.21

2.6

2.1

—

Use of other anti-dementia drugs

0.00

0.21

0.0

1.1

—

Use of memantine

0.00

0.21

0.0

1.1

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.21

0.0

5.2

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

6.2

—

Fall on and from ladder

0.00

0.21

0.0

2.2

—

Macular pucker

0.00

0.20

0.0

1.3

—

Parkinson's disease, strict definition

0.00

0.20

0.0

1.2

—

Hypothyroidism, other/unspecified

186

0.88

0.20

2.0

2.5

—

Obesity due to excess calories

155

0.84

0.20

1.5

2.6

—

Transport accidents

141

1.16

0.20

2.1

2.2

—

Other and unspecified nonorganic psychotic disorders

1.22

0.20

2.2

2.3

—

Lumbar disc prolapse

119

0.84

0.20

1.1

1.4

—

Retention of urine

1.20

0.20

1.0

1.9

—

Type 2 diabetes, wide definition

123

1.14

0.19

1.7

1.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.23

0.19

1.3

1.4

—

Triptan medication for migraine, single purchase ok

195

1.11

0.19

3.2

2.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

195

1.11

0.19

3.2

2.4

—

Sleep apnoea

175

0.89

0.18

1.1

2.0

—

Endometriosis

1.17

0.18

1.1

1.7

—

Irritable bowel syndrome

1.19

0.18

1.9

2.7

—

Pregnancy hypertension

1.23

0.17

1.3

—

Lyme disease

1.11

0.17

2.6

2.3

—

Mental and behavioural disorders due to alcohol

142

1.15

0.17

2.7

2.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.11

0.17

2.0

1.7

—

Acute alcohol intoxication

0.72

0.16

5.4

2.3

—

Type 1 diabetes, strict (exclude DM2)

1.22

0.16

3.4

5.3

—

Scabies

1.18

0.16

5.2

4.0

—

Fall on and from stairs and steps

1.18

0.16

1.4

3.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

157

1.14

0.16

4.1

2.8

—

Hypothyroidism, strict autoimmune

116

1.13

0.16

2.0

2.8

—

Concussion

175

0.89

0.16

3.7

3.0

—

Internal derangement of knee

101

1.18

0.16

1.6

2.4

—

Cervical disc disorders

1.11

0.15

1.1

1.4

—

Obesity, other/unspecified

1.11

0.15

1.2

2.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

188

0.91

0.15

2.0

2.5

—

Mental and behavioural disorders due to psychoactive substance use

165

1.12

0.15

2.4

2.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.80

0.14

2.0

2.2

—

Excessive earwax

177

0.88

0.14

3.5

2.9

—

Fracture of shoulder and upper arm

131

1.14

0.14

3.2

3.0

—

Allergic rhinitis

189

0.89

0.14

1.6

3.9

—

Shoulder lesions

116

0.89

0.13

1.1

1.4

—

Falls/tendency to fall

256

0.94

0.13

3.7

2.8

—

Nerve, nerve root and plexus disorders

169

1.09

0.12

2.1

1.6

—

Sleep apnoea, including avohilmo

182

0.92

0.12

1.1

1.9

—

Substance abuse

161

1.11

0.12

2.5

2.1

—

Diabetes, insulin treatment (Kela reimbursement)

214

0.93

0.11

2.9

2.7

—

Injuries to the hip and thigh

112

1.13

0.11

3.1

2.7

—

Rotator cuff syndrome

103

1.11

0.10

1.1

1.2

—

Pure hypercholesterolaemia

100

1.11

0.10

1.2

1.7

—

Open wound of head

220

0.92

0.10

2.7

3.2

—

Ganglion

1.11

0.09

3.4

1.7

—

Burns and corrosions of external body surface, specified by site

1.09

0.09

2.4

4.7

—

Other fall from one level to another

114

0.88

0.09

5.0

3.8

—

Injury of eye and orbit

1.04

0.09

2.4

3.4

—

Substance use, excluding alcohol

1.04

0.09

1.0

1.9

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.11

0.09

4.3

5.8

—

Pre-eclampsia or poor fetal growth

1.11

0.09

1.2

1.3

—

Myalgia

1.07

0.08

1.7

1.9

—

In situ neoplasms

1.05

0.08

1.8

1.3

—

Glaucoma suspect

1.05

0.08

3.8

1.5

—

Subjective visual disturbances

1.03

0.08

1.0

3.2

—

Antenatal screening

1.06

0.08

1.4

2.0

—

Other intervertebral disc disorders

124

0.92

0.08

1.1

1.4

—

Other symptoms and signs involving cognitive functions and awareness

1.14

0.08

1.0

2.0

—

Spirochaetal infections, other/unspecified

1.09

0.08

2.6

2.3

—

Meniscus derangement

0.90

0.08

1.6

1.4

—

Disorders of vitreous body and globe

1.12

0.07

1.1

1.4

—

Other and unspecified disorders of vitreous body

1.01

0.07

1.1

1.2

—

Suicide or other Intentional self-harm

0.83

0.07

2.2

2.4

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.82

0.07

1.0

1.5

—

Glucagon-like peptide-1 (GLP-1) analogues

0.82

0.07

1.0

1.5

—

Personality disorders

1.08

0.07

1.6

2.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.07

0.07

2.5

2.0

—

Other abnormal products of conception

0.87

0.07

1.7

1.5

—

Caries of dentine, including avohilmo

157

0.94

0.07

3.4

3.3

—

Poisoning by drugs, medicaments and biological substances

0.85

0.07

1.9

2.6

—

Schizophrenia or delusion

0.84

0.07

2.3

1.9

—

Schizophrenia, schizotypal and delusional disorders

0.84

0.07

2.3

1.9

—

Diabetes mellitus in pregnancy

1.05

0.07

1.7

—

Glaucoma

1.12

0.06

2.7

1.5

—

Selective serotonin reuptake inhibitors

180

0.96

0.05

2.1

2.5

—

Injuries to the knee and lower leg

263

1.03

0.05

3.0

2.7

—

Insulin, intermediate and long-acting

164

1.07

0.05

2.3

3.0

—

Arthrosis

0.93

0.04

1.2

1.3

—

Disorders of the thyroid gland

200

1.04

0.04

1.8

2.5

—

Obesity related asthma

1.10

0.04

1.3

2.4

—

Diabetes medication

221

0.97

0.04

2.8

2.6

—

Disorders of vitreous body

1.10

0.04

1.1

1.2

—

Exposure to other specified factors

283

1.04

0.04

2.6

2.8

—

Vasomotor and allergic rhinitis

177

1.05

0.03

1.9

3.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

199

0.97

0.03

3.0

2.7

—

Pregnancy with abortive outcome

0.95

0.02

1.4

1.9

—

Acute appendicitis, no complications

166

0.96

0.01

1.1

1.8

—

Unspecified fall

210

1.03

0.01

4.8

3.2

—

Asthma/COPD (KELA code 203)

269

1.02

0.01

2.5

2.9

—

Other external causes of accidental injury

189

0.98

0.01

3.7

2.8

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.95

0.01

1.5

1.3

—

Other congenital malformations

1.06

0.00

3.1

4.6

—

Other headache syndromes

110

1.00

0.00

3.5

2.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

248

1.00

0.00

3.1

2.6

—

Fracture of forearm

180

1.02

0.00

3.8

2.9

—

Diseases of appendix

194

1.02

0.00

1.6

1.8

—

D07AA Corticosteroids, weak (group I)

108

1.02

0.00

3.5

4.0

—

Gonarthrosis, primary, with knee surgery

0.95

0.00

1.2

—

Accidents

189

1.01

0.00

3.7

2.8

—

Benzodiazepine use

206

1.00

0.00

1.5

2.2

—

Sub-endpoint used in defining T1D endpoints

122

0.97

0.00

4.2

4.0

—

Appendicitis, broad definition

194

0.98

0.00

1.3

1.8

—

Striking against or struck by other objects

165

1.03

0.00

2.1

3.5

—

Other symptoms and signs involving the nervous and musculoskeletal systems

145

1.03

0.00

5.0

3.4

—

Acute appendicitis

189

0.99

0.00

1.2

1.8

—

Type1 diabetes, definitions combined, early onset

0.91

0.00

4.3

5.5

—

Papillary adenocarcinoma of thyroid gland

0.00

0.0

2.2

—

Supervision of high-risk pregnancy

0.88

0.00

1.6

2.0

—

Pectus excavatum

0.00

0.0

7.9

—

Transient global amnesia

0.00

0.0

1.3

—

Microcephaly

0.00

0.0

5.5

—

Pedal cyclist injured in transport accident

1.01

0.00

1.8

3.8

—

Other symptoms and signs involving general sensations and perceptions

0.00

0.0

5.3

—

Reduction defects of upper limb

0.00

0.0

4.4

—

Other noninflammatory disorders of cervix uteri

0.00

0.0

1.6

—

Cluster headache, strict

0.00

0.0

1.8

—

Congenital cataract

0.00

0.0

6.0

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

5.0

—

Benign neoplasm: Adrenal gland

0.00

0.0

1.3

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.0

1.4

—

Congenital ptosis

0.00

0.0

6.0

—

Other disorders of eyelid

0.95

0.00

2.0

1.8

—

Voice disturbances

1.02

0.00

2.8

2.3

—

Other specified and unspecified strabismus

0.00

0.0

3.7

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

1.3

—

Prepatellar bursitis

0.00

-0.00

0.0

2.5

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

-0.00

0.0

2.5

—

Congenital ptosis

0.00

-0.00

0.0

6.0

—

Congenital malformations of genital organs

0.86

-0.00

4.2

5.6

—

Deforming dorsopathies

1.01

-0.00

2.4

3.1

—

Café au lait spots

0.00

-0.00

0.0

4.9

—

Osteogenesis imperfecta

0.00

-0.00

0.0

5.6

—

Mental retardation, wide definition

0.94

-0.00

5.3

5.5

—

Birth injury to skeleton

0.00

-0.00

0.0

6.6

—

Other congenital malformations

0.96

-0.00

3.4

4.9

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

8.0

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

5.2

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

7.2

—

Maternal care for known or suspected abnormality of pelvic organs

1.00

-0.00

1.0

1.6

—

Hypospadias with an incomplete glans penis

0.00

-0.00

0.0

5.6

—

Microtia (small ears)

0.00

-0.00

0.0

6.8

—

Convulsions of newborn

0.00

-0.00

0.0

5.2

—

Reduction defects of upper limb

0.00

-0.00

0.0

4.4

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.3

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of bladder, including Hilmo

0.00

-0.00

0.0

1.4

—

Mastocytosis

0.00

-0.00

0.0

5.0

—

Artificial joint re-operation

0.00

-0.00

0.0

1.0

—

Unspecified visual impairment (binocular)

0.00

-0.00

0.0

6.0

—

Communicating hydrocephalus

0.00

-0.00

0.0

4.3

—

Lesion of plantar nerve

0.00

-0.00

0.0

1.2

—

Mental retardation

0.94

-0.00

5.3

5.5

—

Tuberous sclerosis 1

0.00

-0.00

0.0

3.8

—

Non-small cell lung cancer

0.00

-0.00

0.0

1.3

—

Other osteochondrodysplasias

0.00

-0.00

0.0

4.8

—

Torticollis

0.00

-0.00

0.0

7.0

—

Prominent ears

0.00

-0.00

0.0

5.6

—

Severe mental retardation

0.00

-0.00

0.0

6.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.5

—

Hyperplasia of prostate

0.97

-0.00

1.0

1.1

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

3.4

—

Disorders of adult personality and behaviour

0.90

-0.00

1.6

2.3

—

Schizophrenia or delusion, excluding more controls

0.99

-0.00

2.3

1.5

—

Other osteochondrodysplasias

0.00

-0.00

0.0

4.8

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.00

-0.00

0.0

4.4

—

Superficial injury of wrist and hand

1.00

-0.00

2.7

3.9

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

2.7

—

Testicular dysfunction

0.00

-0.00

0.0

1.8

—

Cluster headache, wide

0.00

-0.00

0.0

1.7

—

Congenital malformations of eye, ear, face and neck

1.00

-0.00

4.8

5.7

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

3.8

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.4

—

Peritonsillar abscess

0.88

-0.00

1.2

2.2

—

Testicular hypofunction

0.00

-0.00

0.0

2.0

—

Non-small cell lung cancer, including Hilmo

0.00

-0.00

0.0

1.2

—

Gender identity disorders

0.00

-0.00

0.0

5.2

—

Congenital hypothyroidism without goiter

0.00

-0.00

0.0

6.2

—

Other secondary gonarthrosis

0.00

-0.00

0.0

1.3

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

1.8

—

Maternal care for other known or suspected fetal problems

0.90

-0.00

1.2

1.8

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.4

—

All dysplastic lesions of the cervix uteri

1.01

-0.00

2.0

1.3

—

Other abnormal immunological findings in serum

0.00

-0.00

0.0

5.0

—

Digeorge syndrome

0.00

-0.00

0.0

3.2

—

Faecal incontinence

0.00

-0.00

0.0

1.2

—

Symptoms and signs involving speech and voice

0.88

-0.00

2.8

2.3

—

Immunodeficiency associated with other major defects

0.00

-0.00

0.0

3.2

—

Olecranon bursitis

0.00

-0.00

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.95

-0.00

5.8

3.8

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.7

—

Tetraplegia

0.00

-0.00

0.0

3.2

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

5.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

3.0

—

Lactose intolerance

0.00

-0.00

0.0

5.0

—

Unspecified event, undetermined intent

0.00

-0.00

0.0

4.0

—

Muscular dystrophy

0.00

-0.00

0.0

7.3

—

Transient ischemic attack

0.97

-0.00

1.1

1.4

—

Glaucoma, exfoliation

0.00

-0.00

0.0

1.2

—

Hereditary retinal dystrophy

0.00

-0.00

0.0

4.8

—

Lymphangioma, anys site

0.00

-0.00

0.0

5.3

—

Contusion of toe(s) without damage to nail

0.00

-0.00

0.0

4.4

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

-0.00

0.0

3.0

—

Down's syndrome

0.00

-0.00

0.0

4.1

—

Alzheimer’s disease (Late onset)

0.00

-0.00

0.0

1.1

—

Extrapyramidal and movement disorders

0.87

-0.00

1.0

2.3

—

Other and unspecified intracranial injuries

0.00

-0.00

0.0

2.0

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

5.2

—

Use of donepezil

0.00

-0.00

0.0

1.1

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

-0.00

0.0

1.4

—

Other surgical follow-up care

0.00

-0.00

0.0

6.0

—

Gonococcal infection

0.00

-0.00

0.0

3.5

—

Cleft hard palate NOS

0.00

-0.00

0.0

6.0

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

7.2

—

Acute alcohol intoxication, ICD10

0.89

-0.00

5.4

2.6

—

Supervision of normal pregnancy

0.98

-0.00

1.7

2.1

—

Calcific tendinitis of shoulder

0.00

-0.00

0.0

1.1

—

Gonococcal infection

0.00

-0.00

0.0

3.2

—

Dermatitis due to ingested food

0.96

-0.00

3.2

5.1

—

Contact with nonpowered hand tool

0.00

-0.00

0.0

2.7

—

Unspecified threat to breathing

0.00

-0.00

0.0

5.7

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

-0.00

0.0

5.2

—

Contact with other hot metals

0.00

-0.00

0.0

5.2

—

Contact with venomous snakes and lizards

0.00

-0.00

0.0

5.2

—

Alcohol-induced chronic pancreatitis

0.00

-0.00

0.0

1.0

—

Amoebiasis

0.00

-0.00

0.0

3.4

—

Congenital lens malformations

0.00

-0.00

0.0

6.0

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

2.6

—

Pectus excavatum

0.00

-0.00

0.0

7.4

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS